<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font20 { font-size : 20; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">migraine </span>
   <span class="font28">headache </span>
   <span class="font26">patients </span>
   <span class="font20">Headache </span>
   <span class="font17">treatment </span>
   <span class="font15">study </span>
   <span class="font15">chronic </span>
   <span class="font15">University </span>
   <span class="font14">Department </span>
   <span class="font14">pain </span>
   <span class="font14">clinical </span>
   <span class="font14">(%) </span>
   <span class="font13">Migraine </span>
   <span class="font13">(.) </span>
   <span class="font13">days </span>
   <span class="font13">(.%) </span>
   <span class="font13">[]. </span>
   <span class="font13">primary </span>
   <span class="font13">data </span>
   <span class="font13">significant </span>
   <span class="font13">aura </span>
   <span class="font12">Italy; </span>
   <span class="font12">Results </span>
   <span class="font12">using </span>
   <span class="font12">associated </span>
   <span class="font12">headaches </span>
   <span class="font12">higher </span>
   <span class="font12">compared </span>
   <span class="font12">reported </span>
   <span class="font12">Background </span>
   <span class="font12">diagnosis </span>
   <span class="font12">placebo </span>
   <span class="font12">significantly </span>
   <span class="font12">mean </span>
   <span class="font12">baseline </span>
   <span class="font12">References </span>
   <span class="font12">number </span>
   <span class="font12">reduction </span>
   <span class="font12">episodic </span>
   <span class="font12">risk </span>
   <span class="font12">frequency </span>
   <span class="font12">attacks </span>
   <span class="font12">years </span>
   <span class="font12">patient </span>
   <span class="font12">migraine. </span>
   <span class="font12">studies </span>
   <span class="font12">used </span>
   <span class="font12">group </span>
   <span class="font12">age </span>
   <span class="font12">showed </span>
   <span class="font12">use </span>
   <span class="font12">medication </span>
   <span class="font12">Italy </span>
   <span class="font12">symptoms </span>
   <span class="font12">brain </span>
   <span class="font12">results </span>
   <span class="font12">analysis </span>
   <span class="font12">Correspondence: </span>
   <span class="font12">Hospital, </span>
   <span class="font11">Medical </span>
   <span class="font11">Neurology, </span>
   <span class="font11">acute </span>
   <span class="font11">Patients </span>
   <span class="font11">Conclusions </span>
   <span class="font11">(abstract </span>
   <span class="font11">children </span>
   <span class="font11">disorders </span>
   <span class="font11">CGRP </span>
   <span class="font11">Chronic </span>
   <span class="font11">treated </span>
   <span class="font11">Clinical </span>
   <span class="font11">International </span>
   <span class="font11">Materials </span>
   <span class="font11">criteria </span>
   <span class="font11">trigeminal </span>
   <span class="font11">(,%) </span>
   <span class="font11">different </span>
   <span class="font11">USA; </span>
   <span class="font11">headache. </span>
   <span class="font11">Center, </span>
   <span class="font11">P). </span>
   <span class="font11">efficacy </span>
   <span class="font11">month </span>
   <span class="font11">Rome, </span>
   <span class="font11">subjects </span>
   <span class="font11">factors </span>
   <span class="font11">role </span>
   <span class="font11">Methods </span>
   <span class="font11">Pain </span>
   <span class="font11">cluster </span>
   <span class="font11">differences </span>
   <span class="font11">effect </span>
   <span class="font11">monthly </span>
   <span class="font11">patients. </span>
   <span class="font11">sleep </span>
   <span class="font11">(.-.) </span>
   <span class="font11">Health </span>
   <span class="font11">migraine, </span>
   <span class="font11">quality </span>
   <span class="font11">common </span>
   <span class="font11">versus </span>
   <span class="font11">headache, </span>
   <span class="font11">nerve </span>
   <span class="font11">fremanezumab </span>
   <span class="font11">prevalence </span>
   <span class="font11">response </span>
   <span class="font11">high </span>
   <span class="font11">impact </span>
   <span class="font11">Centre, </span>
   <span class="font11">erenumab </span>
   <span class="font11">present </span>
   <span class="font11">Medicine, </span>
   <span class="font11">period </span>
   <span class="font11">visual </span>
   <span class="font11">(n=) </span>
   <span class="font11">based </span>
   <span class="font11">groups </span>
   <span class="font11">included </span>
   <span class="font11">secondary </span>
   <span class="font11">cases </span>
   <span class="font11">Classification </span>
   <span class="font11">according </span>
   <span class="font11">performed </span>
   <span class="font11">type </span>
   <span class="font11">Neurology </span>
   <span class="font11">patients, </span>
   <span class="font11">study. </span>
   <span class="font11">.%; </span>
   <span class="font11">case </span>
   <span class="font11">disability </span>
   <span class="font11">months </span>
   <span class="font11">preventive </span>
   <span class="font11">therapy </span>
   <span class="font11">:-. </span>
   <span class="font11">attack </span>
   <span class="font11">intensity </span>
   <span class="font11">methods </span>
   <span class="font11">possible </span>
   <span class="font11">Sciences, </span>
   <span class="font11">new </span>
   <span class="font11">potential </span>
   <span class="font11">association </span>
   <span class="font11">duration </span>
   <span class="font11">management </span>
   <span class="font11">overuse </span>
   <span class="font11">report </span>
   <span class="font11">score </span>
   <span class="font11">greater </span>
   <span class="font11">including </span>
   <span class="font11">related </span>
   <span class="font11">women </span>
   <span class="font11">general </span>
   <span class="font11">total </span>
   <span class="font11">Table </span>
   <span class="font11">central </span>
   <span class="font11">changes </span>
   <span class="font11">did </span>
   <span class="font11">features </span>
   <span class="font11">Fig. </span>
   <span class="font11">activity </span>
   <span class="font11">neck </span>
   <span class="font11">onset </span>
   <span class="font11">specific </span>
   <span class="font11">vs. </span>
   <span class="font11">CM, </span>
   <span class="font11">MRI </span>
   <span class="font11">change </span>
   <span class="font11">left </span>
   <span class="font11">population </span>
   <span class="font11">prophylactic </span>
   <span class="font11">stimulation </span>
   <span class="font11">following </span>
   <span class="font11">migraine: </span>
   <span class="font11">Cephalalgia. </span>
   <span class="font11">assessed </span>
   <span class="font11">level </span>
   <span class="font11">severe </span>
   <span class="font11">University, </span>
   <span class="font11">dose </span>
   <span class="font11">increased </span>
   <span class="font11">time </span>
   <span class="font11">MOH </span>
   <span class="font11">daily </span>
   <span class="font11">effective </span>
   <span class="font11">intracranial </span>
   <span class="font11">severity </span>
   <span class="font10">disease </span>
   <span class="font10">drug </span>
   <span class="font10">right </span>
   <span class="font10">However, </span>
   <span class="font10">observed </span>
   <span class="font10">reduced </span>
   <span class="font10">Center </span>
   <span class="font10">evidence </span>
   <span class="font10">neurological </span>
   <span class="font10">(.%), </span>
   <span class="font10">Teva </span>
   <span class="font10">effects </span>
   <span class="font10">findings </span>
   <span class="font10">history </span>
   <span class="font10">life </span>
   <span class="font10">similar </span>
   <span class="font10">test </span>
   <span class="font10">(-. </span>
   <span class="font10">;:-. </span>
   <span class="font10">considered </span>
   <span class="font10">scores </span>
   <span class="font10">Pharmaceutical </span>
   <span class="font10">USA </span>
   <span class="font10">hours </span>
   <span class="font10">increase </span>
   <span class="font10">[-] </span>
   <span class="font10">cortical </span>
   <span class="font10">phase </span>
   <span class="font10">prophylaxis </span>
   <span class="font10">tension-type </span>
   <span class="font10">.±. </span>
   <span class="font10">European </span>
   <span class="font10">Hospital </span>
   <span class="font10">Neurological </span>
   <span class="font10">Research </span>
   <span class="font10">Results: </span>
   <span class="font10">cerebral </span>
   <span class="font10">drugs </span>
   <span class="font10">mechanisms </span>
   <span class="font10">previously </span>
   <span class="font10">received </span>
   <span class="font10">treatments </span>
   <span class="font10">work </span>
   <span class="font10">diagnostic </span>
   <span class="font10">head </span>
   <span class="font10">nVNS </span>
   <span class="font10">pressure </span>
   <span class="font10">Study </span>
   <span class="font10">characteristics </span>
   <span class="font10">frequent </span>
   <span class="font10">migraineurs </span>
   <span class="font10">(Fig. </span>
   <span class="font10">Conclusion </span>
   <span class="font10">Lipton </span>
   <span class="font10">healthy </span>
   <span class="font10">lower </span>
   <span class="font10">presented </span>
   <span class="font10">therapeutic </span>
   <span class="font10">Cephalalgia </span>
   <span class="font10">Pavia, </span>
   <span class="font10">controls </span>
   <span class="font10">depression </span>
   <span class="font10">important </span>
   <span class="font10">likely </span>
   <span class="font10">outcome </span>
   <span class="font10">followed </span>
   <span class="font10">study, </span>
   <span class="font10">symptomatic </span>
   <span class="font10">triggers </span>
   <span class="font10">Background: </span>
   <span class="font10">Group </span>
   <span class="font10">conditions </span>
   <span class="font10">evaluated </span>
   <span class="font10">peripheral </span>
   <span class="font10">questionnaire </span>
   <span class="font10">sample </span>
   <span class="font10">suggest </span>
   <span class="font10">(EM, </span>
   <span class="font10">Unit, </span>
   <span class="font10">cervical </span>
   <span class="font10">condition </span>
   <span class="font10">conducted </span>
   <span class="font10">disorder </span>
   <span class="font10">minutes </span>
   <span class="font10">participants </span>
   <span class="font10">referred </span>
   <span class="font10">(.% </span>
   <span class="font10">affected </span>
   <span class="font10">aim </span>
   <span class="font10">available </span>
   <span class="font10">control </span>
   <span class="font10">headache: </span>
   <span class="font10">large </span>
   <span class="font10">medical </span>
   <span class="font10">(Table </span>
   <span class="font10">Maria </span>
   <span class="font10">National </span>
   <span class="font10">consecutive </span>
   <span class="font10">demonstrated </span>
   <span class="font10">evaluate </span>
   <span class="font10">frequently </span>
   <span class="font10">injection </span>
   <span class="font10">median </span>
   <span class="font10">pain. </span>
   <span class="font10">recent </span>
   <span class="font10">statistically </span>
   <span class="font10">support </span>
   <span class="font10">treatment. </span>
   <span class="font10">(-) </span>
   <span class="font10">Institute </span>
   <span class="font10">Science </span>
   <span class="font10">active </span>
   <span class="font10">blood </span>
   <span class="font10">evaluation </span>
   <span class="font10">headaches. </span>
   <span class="font10">imaging </span>
   <span class="font10">improvement </span>
   <span class="font10">individuals </span>
   <span class="font10">low </span>
   <span class="font10">model </span>
   <span class="font10">obtained </span>
   <span class="font10">Brain </span>
   <span class="font10">Methods: </span>
   <span class="font10">Pain. </span>
   <span class="font10">aimed </span>
   <span class="font10">cause </span>
   <span class="font10">classification </span>
   <span class="font10">dosing </span>
   <span class="font10">medications </span>
   <span class="font10">range </span>
   <span class="font10">relationship </span>
   <span class="font10">sensory </span>
   <span class="font10">stroke </span>
   <span class="font10">vascular </span>
   <span class="font10">(p&amp;lt;.) </span>
   <span class="font10">Medicine </span>
   <span class="font10">average </span>
   <span class="font10">completed </span>
   <span class="font10">difference </span>
   <span class="font10">identified </span>
   <span class="font10">identify </span>
   <span class="font10">receptor </span>
   <span class="font10">&amp;lt;. </span>
   <span class="font10">Centre </span>
   <span class="font10">Headache. </span>
   <span class="font10">School </span>
   <span class="font10">administration </span>
   <span class="font10">characterized </span>
   <span class="font10">correlation </span>
   <span class="font10">cortex </span>
   <span class="font10">edition </span>
   <span class="font10">mild </span>
   <span class="font10">pediatric </span>
   <span class="font10">recorded </span>
   <span class="font10">suffering </span>
   <span class="font10">symptom </span>
   <span class="font10">trials </span>
   <span class="font10">trigger </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">(mean </span>
   <span class="font10">College </span>
   <span class="font10">Neurol </span>
   <span class="font10">Treatment </span>
   <span class="font10">aura. </span>
   <span class="font10">beta </span>
   <span class="font10">comorbidities </span>
   <span class="font10">doses </span>
   <span class="font10">double-blind, </span>
   <span class="font10">health </span>
   <span class="font10">levels </span>
   <span class="font10">main </span>
   <span class="font10">monoclonal </span>
   <span class="font10">neuroimaging </span>
   <span class="font10">normal </span>
   <span class="font10">pain, </span>
   <span class="font10">physical </span>
   <span class="font10">presence </span>
   <span class="font10">recruited </span>
   <span class="font10">respondents </span>
   <span class="font10">shown </span>
   <span class="font10">weeks </span>
   <span class="font10">(CM) </span>
   <span class="font10">.). </span>
   <span class="font10">CA, </span>
   <span class="font10">Conclusion: </span>
   <span class="font10">Global </span>
   <span class="font10">OnabotulinumtoxinA </span>
   <span class="font10">Sapienza </span>
   <span class="font10">anxiety </span>
   <span class="font10">controlled </span>
   <span class="font10">defined </span>
   <span class="font10">order </span>
   <span class="font10">pharmacological </span>
   <span class="font10">single </span>
   <span class="font10">-week </span>
   <span class="font10">Mean </span>
   <span class="font10">UK; </span>
   <span class="font10">adverse </span>
   <span class="font10">and/or </span>
   <span class="font10">autonomic </span>
   <span class="font10">diary </span>
   <span class="font10">follow-up </span>
   <span class="font10">functional </span>
   <span class="font10">involved </span>
   <span class="font10">occurrence </span>
   <span class="font10">overall </span>
   <span class="font10">reduce </span>
   <span class="font10">.), </span>
   <span class="font10">CPH </span>
   <span class="font10">Paolo </span>
   <span class="font10">point </span>
   <span class="font10">prevention </span>
   <span class="font10">previous </span>
   <span class="font10">proportion </span>
   <span class="font10">provided </span>
   <span class="font10">review </span>
   <span class="font10">survey </span>
   <span class="font10">tests </span>
   <span class="font10">;():-. </span>
   <span class="font10">Fremanezumab </span>
   <span class="font10">Martelletti </span>
   <span class="font10">Novartis </span>
   <span class="font10">better </span>
   <span class="font10">combination </span>
   <span class="font10">dural </span>
   <span class="font10">events </span>
   <span class="font10">improve </span>
   <span class="font10">literature </span>
   <span class="font10">months. </span>
   <span class="font10">profile </span>
   <span class="font10">prospective </span>
   <span class="font10">psychological </span>
   <span class="font10">rare </span>
   <span class="font10">site </span>
   <span class="font10">tolerability </span>
   <span class="font10">topiramate </span>
   <span class="font10">various </span>
   <span class="font10">BoNT-A </span>
   <span class="font10">Data </span>
   <span class="font10">Disorders, </span>
   <span class="font10">approach </span>
   <span class="font10">assess </span>
   <span class="font10">burden </span>
   <span class="font10">cognitive </span>
   <span class="font10">complete </span>
   <span class="font10">confirmed </span>
   <span class="font10">consent </span>
   <span class="font10">day </span>
   <span class="font10">gene-related </span>
   <span class="font10">impairment </span>
   <span class="font10">investigate </span>
   <span class="font10">measured </span>
   <span class="font10">onabotulinumtoxinA </span>
   <span class="font10">past </span>
   <span class="font10">randomized </span>
   <span class="font10">suspected </span>
   <span class="font10">systematic </span>
   <span class="font10">.%, </span>
   <span class="font10">Disorders </span>
   <span class="font10">Italian </span>
   <span class="font10">Paul </span>
   <span class="font10">Sleep </span>
   <span class="font10">analyzed </span>
   <span class="font10">cohort </span>
   <span class="font10">compare </span>
   <span class="font10">development </span>
   <span class="font10">examination </span>
   <span class="font10">female </span>
   <span class="font10">fully </span>
   <span class="font10">information </span>
   <span class="font10">injury </span>
   <span class="font10">poor </span>
   <span class="font10">positive </span>
   <span class="font10">reductions </span>
   <span class="font10">regarding </span>
   <span class="font10">relative </span>
   <span class="font10">safety </span>
   <span class="font10">times </span>
   <span class="font10">treatment, </span>
   <span class="font10">years, </span>
   <span class="font10">Department, </span>
   <span class="font10">Florence, </span>
   <span class="font10">Martin </span>
   <span class="font10">Moreover, </span>
   <span class="font10">TTH </span>
   <span class="font10">[,]. </span>
   <span class="font10">adults </span>
   <span class="font10">developed </span>
   <span class="font10">diagnosed </span>
   <span class="font10">improved </span>
   <span class="font10">include </span>
   <span class="font10">light </span>
   <span class="font10">occipital </span>
   <span class="font10">rate </span>
   <span class="font10">trial </span>
   <span class="font10">aged </span>
   <span class="font10">body </span>
   <span class="font10">days. </span>
   <span class="font10">described </span>
   <span class="font10">especially </span>
   <span class="font10">experience </span>
   <span class="font10">frequency, </span>
   <span class="font10">headaches, </span>
   <span class="font10">known </span>
   <span class="font10">loss </span>
   <span class="font10">observational </span>
   <span class="font10">placebo. </span>
   <span class="font10">presentation </span>
   <span class="font10">sensitization </span>
   <span class="font10">toxin </span>
   <span class="font10">(p=.) </span>
   <span class="font10">Goadsby </span>
   <span class="font10">[], </span>
   <span class="font10">age, </span>
   <span class="font10">area </span>
   <span class="font10">classified </span>
   <span class="font10">combined </span>
   <span class="font10">controls. </span>
   <span class="font10">dysfunction </span>
   <span class="font10">experienced </span>
   <span class="font10">having </span>
   <span class="font10">ischemic </span>
   <span class="font10">moderate </span>
   <span class="font10">negative </span>
   <span class="font10">oral </span>
   <span class="font10">pathophysiology </span>
   <span class="font10">placebo-controlled </span>
   <span class="font10">population. </span>
   <span class="font10">quarterly </span>
   <span class="font10">respectively. </span>
   <span class="font10">subcutaneous </span>
   <span class="font10">tension </span>
   <span class="font10">visits </span>
   <span class="font10">(p&amp;lt;.). </span>
   <span class="font10">CSD </span>
   <span class="font10">HIT- </span>
   <span class="font10">Jensen </span>
   <span class="font10">Neuroscience </span>
   <span class="font10">Sciences </span>
   <span class="font10">Society </span>
   <span class="font10">Total </span>
   <span class="font10">action </span>
   <span class="font10">additional </span>
   <span class="font10">current </span>
   <span class="font10">days, </span>
   <span class="font10">disorders. </span>
   <span class="font10">emergency </span>
   <span class="font10">individual </span>
   <span class="font10">majority </span>
   <span class="font10">mechanism </span>
   <span class="font10">need </span>
   <span class="font10">nociceptive </span>
   <span class="font10">p=.) </span>
   <span class="font10">peptide </span>
   <span class="font10">underwent </span>
   <span class="font10">(). </span>
   <span class="font10">(−., </span>
   <span class="font10">Case </span>
   <span class="font10">Consent </span>
   <span class="font10">Danish </span>
   <span class="font10">Federico </span>
   <span class="font10">Richard </span>
   <span class="font10">TRPA </span>
   <span class="font10">Tassorelli </span>
   <span class="font10">assessment </span>
   <span class="font10">attachment </span>
   <span class="font10">aura, </span>
   <span class="font10">calcitonin </span>
   <span class="font10">days/month </span>
   <span class="font10">detoxification </span>
   <span class="font10">disabling </span>
   <span class="font10">disorders, </span>
   <span class="font10">form </span>
   <span class="font10">genetic </span>
   <span class="font10">long </span>
   <span class="font10">mg, </span>
   <span class="font10">nervous </span>
   <span class="font10">occurred </span>
   <span class="font10">prior </span>
   <span class="font10">refractory </span>
   <span class="font10">relevant </span>
   <span class="font10">temporal </span>
   <span class="font10">tissue </span>
   <span class="font10">week </span>
   <span class="font10">(beta </span>
   <span class="font10">-month </span>
   <span class="font10">Barbara </span>
   <span class="font10">Behavioral </span>
   <span class="font10">Committee </span>
   <span class="font10">Institute, </span>
   <span class="font10">Pediatric </span>
   <span class="font10">antibody </span>
   <span class="font10">attributed </span>
   <span class="font10">decrease </span>
   <span class="font10">direct </span>
   <span class="font10">end </span>
   <span class="font10">flexion </span>
   <span class="font10">good </span>
   <span class="font10">human </span>
   <span class="font10">informed </span>
   <span class="font10">muscles </span>
   <span class="font10">needed </span>
   <span class="font10">objective </span>
   <span class="font10">people </span>
   <span class="font10">platform </span>
   <span class="font10">randomized, </span>
   <span class="font10">selected </span>
   <span class="font10">sensitivity </span>
   <span class="font10">useful </span>
   <span class="font10">.±., </span>
   <span class="font10">Clinic, </span>
   <span class="font10">Conclusions: </span>
   <span class="font10">IIH </span>
   <span class="font10">Industries. </span>
   <span class="font10">Medication </span>
   <span class="font10">activation </span>
   <span class="font10">attacks. </span>
   <span class="font10">care </span>
   <span class="font10">collected </span>
   <span class="font10">comparison </span>
   <span class="font10">confirm </span>
   <span class="font10">enrolled </span>
   <span class="font10">induced </span>
   <span class="font10">injections </span>
   <span class="font10">larger </span>
   <span class="font10">major </span>
   <span class="font10">p&amp;lt;.) </span>
   <span class="font10">placebo, </span>
   <span class="font10">provide </span>
   <span class="font10">psychiatric </span>
   <span class="font10">regimens </span>
   <span class="font10">started </span>
   <span class="font10">status </span>
   <span class="font10">tertiary </span>
   <span class="font10">therapies </span>
   <span class="font10">(): </span>
   <span class="font10">(p=.). </span>
   <span class="font10">.%), </span>
   <span class="font10">;:–. </span>
   <span class="font10">Compared </span>
   <span class="font10">Elena </span>
   <span class="font10">Impact </span>
   <span class="font10">Industries, </span>
   <span class="font10">Neurol. </span>
   <span class="font10">P&amp;lt;.). </span>
   <span class="font10">Physical </span>
   <span class="font10">Trial </span>
   <span class="font10">alcohol </span>
   <span class="font10">areas </span>
   <span class="font10">cycle </span>
   <span class="font10">facial </span>
   <span class="font10">factor </span>
   <span class="font10">free </span>
   <span class="font10">intake </span>
   <span class="font10">lasting </span>
   <span class="font10">magnesium </span>
   <span class="font10">p&amp;lt;.). </span>
   <span class="font10">patients’ </span>
   <span class="font10">period. </span>
   <span class="font10">persistent </span>
   <span class="font10">revealed </span>
   <span class="font10">scale </span>
   <span class="font10">second </span>
   <span class="font10">seen </span>
   <span class="font10">suggests </span>
   <span class="font10">symptoms, </span>
   <span class="font10">syndrome </span>
   <span class="font10">taken </span>
   <span class="font10">target </span>
   <span class="font10">therapy. </span>
   <span class="font10">value </span>
   <span class="font10">(.%). </span>
   <span class="font10">(OR </span>
   <span class="font10">-year </span>
   <span class="font10">Antonio </span>
   <span class="font10">Applied </span>
   <span class="font10">Birmingham, </span>
   <span class="font10">Copenhagen, </span>
   <span class="font10">Curr </span>
   <span class="font10">Efficacy </span>
   <span class="font10">Inc., </span>
   <span class="font10">MA, </span>
   <span class="font10">Molecular </span>
   <span class="font10">Outcomes </span>
   <span class="font10">Research, </span>
   <span class="font10">Sacco </span>
   <span class="font10">Tanacethum </span>
   <span class="font10">analyses </span>
   <span class="font10">block </span>
   <span class="font10">cerebrospinal </span>
   <span class="font10">comorbid </span>
   <span class="font10">days) </span>
   <span class="font10">determine </span>
   <span class="font10">domain </span>
   <span class="font10">effectiveness </span>
   <span class="font10">electronic </span>
   <span class="font10">emotional </span>
   <span class="font10">exposure </span>
   <span class="font10">incidence </span>
   <span class="font10">matched </span>
   <span class="font10">neuropathic </span>
   <span class="font10">novel </span>
   <span class="font10">posterior </span>
   <span class="font10">prevalent </span>
   <span class="font10">productivity </span>
   <span class="font10">regression </span>
   <span class="font10">sinus </span>
   <span class="font10">symptoms. </span>
   <span class="font10">typical </span>
   <span class="font10">underlying </span>
   <span class="font10">vein </span>
   <span class="font10">weight </span>
   <span class="font10">(CGRP) </span>
   <span class="font10">AG, </span>
   <span class="font10">Allergan </span>
   <span class="font10">Child </span>
   <span class="font10">Denmark; </span>
   <span class="font10">Faculty </span>
   <span class="font10">IRCCS </span>
   <span class="font10">Laura </span>
   <span class="font10">MIDAS </span>
   <span class="font10">Mondino </span>
   <span class="font10">Negro </span>
   <span class="font10">Sances </span>
   <span class="font10">administered </span>
   <span class="font10">cranial </span>
   <span class="font10">fluid </span>
   <span class="font10">indicate </span>
   <span class="font10">mg) </span>
   <span class="font10">parameters </span>
   <span class="font10">percentage </span>
   <span class="font10">presenting </span>
   <span class="font10">proposed </span>
   <span class="font10">respectively </span>
   <span class="font10">responses </span>
   <span class="font10">spreading </span>
   <span class="font10">standard </span>
   <span class="font10">statistical </span>
   <span class="font10">studies. </span>
   <span class="font10">suggested </span>
   <span class="font10">terms </span>
   <span class="font10">values </span>
   <span class="font10">{border-style </span>
   <span class="font10">(e.g., </span>
   <span class="font10">Children </span>
   <span class="font10">Clinic </span>
   <span class="font10">Cristina </span>
   <span class="font10">Erenumab </span>
   <span class="font10">Eur </span>
   <span class="font10">L’Aquila, </span>
   <span class="font10">Participants </span>
   <span class="font10">Prevalence </span>
   <span class="font10">RDA </span>
   <span class="font10">Ribeirão </span>
   <span class="font10">School, </span>
   <span class="font10">Simona </span>
   <span class="font10">Therefore, </span>
   <span class="font10">Valeriani </span>
   <span class="font10">able </span>
   <span class="font10">analgesic </span>
   <span class="font10">and, </span>
   <span class="font10">application </span>
   <span class="font10">asked </span>
   <span class="font10">benefit </span>
   <span class="font10">comorbidity </span>
   <span class="font10">days; </span>
   <span class="font10">description </span>
   <span class="font10">early </span>
   <span class="font10">episodes </span>
   <span class="font10">forms </span>
   <span class="font10">galcanezumab </span>
   <span class="font10">ganglion </span>
   <span class="font10">gene </span>
   <span class="font10">groups. </span>
   <span class="font10">investigated </span>
   <span class="font10">magnetic </span>
   <span class="font10">men </span>
   <span class="font10">migraines </span>
   <span class="font10">multiple </span>
   <span class="font10">neuralgia </span>
   <span class="font10">non-migraine </span>
   <span class="font10">preliminary </span>
   <span class="font10">questionnaires </span>
   <span class="font10">release </span>
   <span class="font10">resulted </span>
   <span class="font10">series </span>
   <span class="font10">set </span>
   <span class="font10">shows </span>
   <span class="font10">spontaneous </span>
   <span class="font10">subjects. </span>
   <span class="font10">text </span>
   <span class="font10">version). </span>
   <span class="font10">(IQR) </span>
   <span class="font10">Acknowledgements </span>
   <span class="font10">CM. </span>
   <span class="font10">CSF </span>
   <span class="font10">Carlo </span>
   <span class="font10">Curelator </span>
   <span class="font10">Disability </span>
   <span class="font10">Employee </span>
   <span class="font10">Ernesto </span>
   <span class="font10">Francesca </span>
   <span class="font10">Francesco </span>
   <span class="font10">Germany; </span>
   <span class="font10">Giorgio </span>
   <span class="font10">Headaches </span>
   <span class="font10">ICHD- </span>
   <span class="font10">Istituto </span>
   <span class="font10">Japanese </span>
   <span class="font10">Lee </span>
   <span class="font10">Nappi </span>
   <span class="font10">P&amp;lt;.) </span>
   <span class="font10">PACAP </span>
   <span class="font10">Primary </span>
   <span class="font10">Silberstein </span>
   <span class="font10">Unit </span>
   <span class="font10">United </span>
   <span class="font10">ability </span>
   <span class="font10">acetazolamide </span>
   <span class="font10">affect </span>
   <span class="font10">anterior </span>
   <span class="font10">commonly </span>
   <span class="font10">degree </span>
   <span class="font10">diseases </span>
   <span class="font10">given </span>
   <span class="font10">groups, </span>
   <span class="font10">guidelines </span>
   <span class="font10">limited </span>
   <span class="font10">month. </span>
   <span class="font10">neural </span>
   <span class="font10">neuronal </span>
   <span class="font10">open </span>
   <span class="font10">period, </span>
   <span class="font10">physician </span>
   <span class="font10">px;} </span>
   <span class="font10">reducing </span>
   <span class="font10">responders </span>
   <span class="font10">signs </span>
   <span class="font10">taking </span>
   <span class="font10">transient </span>
   <span class="font10">tryptophan </span>
   <span class="font10">types </span>
   <span class="font10">users </span>
   <span class="font10">usually </span>
   <span class="font10">vagus </span>
   <span class="font10">version </span>
   <span class="font10">were: </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">(%), </span>
   <span class="font10">(., </span>
   <span class="font10">(EM) </span>
   <span class="font10">(N=) </span>
   <span class="font10">;:. </span>
   <span class="font10">Anger </span>
   <span class="font10">Athens, </span>
   <span class="font10">Bambino </span>
   <span class="font10">Children’s </span>
   <span class="font10">Diener </span>
   <span class="font10">Federation </span>
   <span class="font10">ICHD-III </span>
   <span class="font10">Jan </span>
   <span class="font10">London, </span>
   <span class="font10">Lorenzo </span>
   <span class="font10">Magnesium </span>
   <span class="font10">Neuroscience, </span>
   <span class="font10">New </span>
   <span class="font10">Padua, </span>
   <span class="font10">Regional </span>
   <span class="font10">Stephen </span>
   <span class="font10">activities </span>
   <span class="font10">adolescents </span>
   <span class="font10">adult </span>
   <span class="font10">beginning </span>
   <span class="font10">clinic </span>
   <span class="font10">complex </span>
   <span class="font10">currently </span>
   <span class="font10">does </span>
   <span class="font10">features, </span>
   <span class="font10">females </span>
   <span class="font10">function </span>
   <span class="font10">group. </span>
   <span class="font10">highly </span>
   <span class="font10">hypertension </span>
   <span class="font10">increasing </span>
   <span class="font10">influence </span>
   <span class="font10">investigation </span>
   <span class="font10">lead </span>
   <span class="font10">lesion </span>
   <span class="font10">longer </span>
   <span class="font10">matter </span>
   <span class="font10">measures </span>
   <span class="font10">n=) </span>
   <span class="font10">occurring </span>
   <span class="font10">particular </span>
   <span class="font10">pattern </span>
   <span class="font10">points </span>
   <span class="font10">predictors </span>
   <span class="font10">preventative </span>
   <span class="font10">published </span>
   <span class="font10">pulse </span>
   <span class="font10">recently </span>
   <span class="font10">repeated </span>
   <span class="font10">reported. </span>
   <span class="font10">represent </span>
   <span class="font10">resolution </span>
   <span class="font10">sham </span>
   <span class="font10">spinal </span>
   <span class="font10">suffer </span>
   <span class="font10">sufferers </span>
   <span class="font10">vitamin </span>
   <span class="font10">withdrawal </span>
   <span class="font10">written </span>
   <span class="font10">ACT </span>
   <span class="font10">Age </span>
   <span class="font10">Association </span>
   <span class="font10">Bronx, </span>
   <span class="font10">Cefalee </span>
   <span class="font10">Coppola </span>
   <span class="font10">Cortical </span>
   <span class="font10">Denmark </span>
   <span class="font10">Emergency </span>
   <span class="font10">Greece; </span>
   <span class="font10">Maggioni </span>
   <span class="font10">Mainardi </span>
   <span class="font10">Overuse </span>
   <span class="font10">PREEMPT </span>
   <span class="font10">SAI </span>
   <span class="font10">Scale </span>
   <span class="font10">Test </span>
   <span class="font10">Week </span>
   <span class="font10">attacks, </span>
   <span class="font10">childhood </span>
   <span class="font10">clinically </span>
   <span class="font10">correlated </span>
   <span class="font10">course </span>
   <span class="font10">della </span>
   <span class="font10">depression, </span>
   <span class="font10">detected </span>
   <span class="font10">device </span>
   <span class="font10">diet </span>
   <span class="font10">differ </span>
   <span class="font10">efficacy, </span>
   <span class="font10">evoked </span>
   <span class="font10">funded </span>
   <span class="font10">group, </span>
   <span class="font10">help </span>
   <span class="font10">hospital </span>
   <span class="font10">hypothalamus </span>
   <span class="font10">importance </span>
   <span class="font10">intensity, </span>
   <span class="font10">leading </span>
   <span class="font10">life, </span>
   <span class="font10">like </span>
   <span class="font10">mainly </span>
   <span class="font10">maximal </span>
   <span class="font10">meningeal </span>
   <span class="font10">multicenter, </span>
   <span class="font10">n=; </span>
   <span class="font10">old </span>
   <span class="font10">outcomes </span>
   <span class="font10">prevent </span>
   <span class="font10">program </span>
   <span class="font10">publication: </span>
   <span class="font10">puncture </span>
   <span class="font10">randomised </span>
   <span class="font10">randomly </span>
   <span class="font10">receptors </span>
   <span class="font10">registration </span>
   <span class="font10">relation </span>
   <span class="font10">remission </span>
   <span class="font10">represents </span>
   <span class="font10">resonance </span>
   <span class="font10">safety, </span>
   <span class="font10">selectively </span>
   <span class="font10">self-reported </span>
   <span class="font10">specialist </span>
   <span class="font10">subgroup </span>
   <span class="font10">supported </span>
   <span class="font10">system, </span>
   <span class="font10">tested </span>
   <span class="font10">years) </span>
   <span class="font10">years. </span>
   <span class="font10">(MOH) </span>
   <span class="font10">.-.; </span>
   <span class="font10">According </span>
   <span class="font10">Allergan, </span>
   <span class="font10">Aycardi </span>
   <span class="font10">Baseline </span>
   <span class="font10">Botulinum </span>
   <span class="font10">CTTH </span>
   <span class="font10">Centro </span>
   <span class="font10">Cluster </span>
   <span class="font10">Epidemiology </span>
   <span class="font10">Foundation </span>
   <span class="font10">Geppetti </span>
   <span class="font10">ICP </span>
   <span class="font10">Life </span>
   <span class="font10">Lionetto </span>
   <span class="font10">Massimiliano </span>
   <span class="font10">Material </span>
   <span class="font10">NCT </span>
   <span class="font10">Neurology. </span>
   <span class="font10">Neurophysiology </span>
   <span class="font10">Paola </span>
   <span class="font10">Phase </span>
   <span class="font10">Robert </span>
   <span class="font10">antibodies </span>
   <span class="font10">aura: </span>
   <span class="font10">avoid </span>
   <span class="font10">caused </span>
   <span class="font10">children’s </span>
   <span class="font10">choice </span>
   <span class="font10">consensus </span>
   <span class="font10">cost </span>
   <span class="font10">crucial </span>
   <span class="font10">diagnosis. </span>
   <span class="font10">divided </span>
   <span class="font10">estimated </span>
   <span class="font10">follow-up. </span>
   <span class="font10">hormonal </span>
   <span class="font10">improvements </span>
   <span class="font10">index </span>
   <span class="font10">indirect </span>
   <span class="font10">inhibition </span>
   <span class="font10">long-term </span>
   <span class="font10">make </span>
   <span class="font10">mass </span>
   <span class="font10">measure </span>
   <span class="font10">medication-overuse </span>
   <span class="font10">mixed </span>
   <span class="font10">models </span>
   <span class="font10">multidisciplinary </span>
   <span class="font10">observation </span>
   <span class="font10">occurs </span>
   <span class="font10">open-label </span>
   <span class="font10">painful </span>
   <span class="font10">pathway </span>
   <span class="font10">pilot </span>
   <span class="font10">pooled </span>
   <span class="font10">post </span>
   <span class="font10">procedure </span>
   <span class="font10">protocol </span>
   <span class="font10">publication. </span>
   <span class="font10">receive </span>
   <span class="font10">research </span>
   <span class="font10">sex </span>
   <span class="font10">signal </span>
   <span class="font10">small </span>
   <span class="font10">superior </span>
   <span class="font10">that, </span>
   <span class="font10">traumatic </span>
   <span class="font10">treat </span>
   <span class="font10">treatments, </span>
   <span class="font10">treatments. </span>
   <span class="font10">trigeminovascular </span>
   <span class="font10">understanding </span>
   <span class="font10">variable </span>
   <span class="font10">visit </span>
   <span class="font10">year </span>
   <span class="font10">years). </span>
   <span class="font10">−.) </span>
   <span class="font10">%). </span>
   <span class="font10">(n=), </span>
   <span class="font10">(with </span>
   <span class="font10">ASL </span>
   <span class="font10">Analysis </span>
   <span class="font10">Berlin, </span>
   <span class="font10">Caucasian </span>
   <span class="font10">Conclusions. </span>
   <span class="font10">Dodick </span>
   <span class="font10">HFEM </span>
   <span class="font10">Health, </span>
   <span class="font10">Katsarava </span>
   <span class="font10">Michele </span>
   <span class="font10">Norway; </span>
   <span class="font10">P=.). </span>
   <span class="font10">Paulo, </span>
   <span class="font10">Quality </span>
   <span class="font10">Subjects </span>
   <span class="font10">São </span>
   <span class="font10">Trigeminal </span>
   <span class="font10">Zanchin </span>
   <span class="font10">abnormalities </span>
   <span class="font10">achieved </span>
   <span class="font10">analgesics </span>
   <span class="font10">antigen </span>
   <span class="font10">assessing </span>
   <span class="font10">assigned </span>
   <span class="font10">baseline, </span>
   <span class="font10">botulinum </span>
   <span class="font10">brainstem </span>
   <span class="font10">called </span>
   <span class="font10">causes </span>
   <span class="font10">comparing </span>
   <span class="font10">confidence </span>
   <span class="font10">consisted </span>
   <span class="font10">costs </span>
   <span class="font10">criteria. </span>
   <span class="font10">cross-sectional </span>
   <span class="font10">declare </span>
   <span class="font10">decreased </span>
   <span class="font10">develop </span>
   <span class="font10">elevated </span>
   <span class="font10">excitability </span>
   <span class="font10">failure </span>
   <span class="font10">family </span>
   <span class="font10">final </span>
   <span class="font10">focal </span>
   <span class="font10">global </span>
   <span class="font10">humanized </span>
   <span class="font10">international </span>
   <span class="font10">investigations </span>
   <span class="font10">key </span>
   <span class="font10">males </span>
   <span class="font10">medial </span>
   <span class="font10">migraineurs. </span>
   <span class="font10">migrainous </span>
   <span class="font10">necessary </span>
   <span class="font10">neurons </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">play </span>
   <span class="font10">potentially </span>
   <span class="font10">ratio </span>
   <span class="font10">recurrent </span>
   <span class="font10">reflex </span>
   <span class="font10">region </span>
   <span class="font10">relief </span>
   <span class="font10">require </span>
   <span class="font10">respect </span>
   <span class="font10">result </span>
   <span class="font10">retrospective </span>
   <span class="font10">score, </span>
   <span class="font10">serum </span>
   <span class="font10">severity, </span>
   <span class="font10">social </span>
   <span class="font10">targets </span>
   <span class="font10">understand </span>
   <span class="font10">unique </span>
   <span class="font10">worsening </span>
   <span class="font10">(%). </span>
   <span class="font10">(CaMEO) </span>
   <span class="font10">(SD) </span>
   <span class="font10">AEs </span>
   <span class="font10">Albert </span>
   <span class="font10">Amgen </span>
   <span class="font10">Benemei </span>
   <span class="font10">Buse </span>
   <span class="font10">CI) </span>
   <span class="font10">Cherubino </span>
   <span class="font10">Diagnostic </span>
   <span class="font10">Ferdinando </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">Glostrup, </span>
   <span class="font10">Imaging </span>
   <span class="font10">JM, </span>
   <span class="font10">Korea; </span>
   <span class="font10">MHD </span>
   <span class="font10">Manack </span>
   <span class="font10">NY, </span>
   <span class="font10">Oaks, </span>
   <span class="font10">P=.) </span>
   <span class="font10">Pamela </span>
   <span class="font10">Pennsylvania, </span>
   <span class="font10">Results. </span>
   <span class="font10">SAH </span>
   <span class="font10">STRIVE </span>
   <span class="font10">San </span>
   <span class="font10">TIA </span>
   <span class="font10">Thousand </span>
   <span class="font10">Yang </span>
   <span class="font10">adherence </span>
   <span class="font10">alexithymia </span>
   <span class="font10">alterations </span>
   <span class="font10">amplitude </span>
   <span class="font10">anger </span>
   <span class="font10">annual </span>
   <span class="font10">applied </span>
   <span class="font10">aspects </span>
   <span class="font10">blocks </span>
   <span class="font10">cardiovascular </span>
   <span class="font10">cerebellar </span>
   <span class="font10">channels </span>
   <span class="font10">claims </span>
   <span class="font10">comparable </span>
   <span class="font10">computed </span>
   <span class="font10">correlations </span>
   <span class="font10">countries </span>
   <span class="font10">density </span>
   <span class="font10">digital </span>
   <span class="font10">education </span>
   <span class="font10">epidemiological </span>
   <span class="font10">explore </span>
   <span class="font10">expressed </span>
   <span class="font10">expression </span>
   <span class="font10">half </span>
   <span class="font10">idiopathic </span>
   <span class="font10">involvement </span>
   <span class="font10">lack </span>
   <span class="font10">level. </span>
   <span class="font10">longitudinal </span>
   <span class="font10">male </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">mood </span>
   <span class="font10">neuropsychiatric </span>
   <span class="font10">occur </span>
   <span class="font10">optimal </span>
   <span class="font10">p&amp;lt;. </span>
   <span class="font10">p=. </span>
   <span class="font10">paroxysmal </span>
   <span class="font10">performance </span>
   <span class="font10">personality </span>
   <span class="font10">population, </span>
   <span class="font10">prescribed </span>
   <span class="font10">process </span>
   <span class="font10">progressive </span>
   <span class="font10">rates </span>
   <span class="font10">records </span>
   <span class="font10">registered </span>
   <span class="font10">reporting </span>
   <span class="font10">responder </span>
   <span class="font10">review. </span>
   <span class="font10">specificity </span>
   <span class="font10">starting </span>
   <span class="font10">structural </span>
   <span class="font10">structured </span>
   <span class="font10">substantial </span>
   <span class="font10">time. </span>
   <span class="font10">tool </span>
   <span class="font10">topiramate, </span>
   <span class="font10">trials. </span>
   <span class="font10">use, </span>
   <span class="font10">volunteers </span>
   <span class="font10">&amp;gt; </span>
   <span class="font10">():-. </span>
   <span class="font10">(.±. </span>
   <span class="font10">(p&amp;lt;.), </span>
   <span class="font10">-). </span>
   <span class="font10">.±.; </span>
   <span class="font10">ASST </span>
   <span class="font10">Aim </span>
   <span class="font10">Alessandro </span>
   <span class="font10">Assessment </span>
   <span class="font10">Basel, </span>
   <span class="font10">Bologna, </span>
   <span class="font10">Conflict </span>
   <span class="font10">Depression </span>
   <span class="font10">Despite </span>
   <span class="font10">Diagnosis </span>
   <span class="font10">Donoghue </span>
   <span class="font10">EDS </span>
   <span class="font10">Einstein </span>
   <span class="font10">Episodic </span>
   <span class="font10">Foundation, </span>
   <span class="font10">Grazia </span>
   <span class="font10">Headache, </span>
   <span class="font10">Irvine, </span>
   <span class="font10">MA. </span>
   <span class="font10">Marco </span>
   <span class="font10">Maternal </span>
   <span class="font10">NC, </span>
   <span class="font10">Neck </span>
   <span class="font10">Neurosciences, </span>
   <span class="font10">Ospedale </span>
   <span class="font10">PR, </span>
   <span class="font10">Pharma </span>
   <span class="font10">Piero </span>
   <span class="font10">Pini </span>
   <span class="font10">Reed </span>
   <span class="font10">Rome </span>
   <span class="font10">Sci. </span>
   <span class="font10">Silvia </span>
   <span class="font10">TMD </span>
   <span class="font10">Vit </span>
   <span class="font10">Weeks </span>
   <span class="font10">Yeung </span>
   <span class="font10">Yuju </span>
   <span class="font10">[-]. </span>
   <span class="font10">addition, </span>
   <span class="font10">address </span>
   <span class="font10">algorithm </span>
   <span class="font10">allodynia </span>
   <span class="font10">animal </span>
   <span class="font10">anxiety, </span>
   <span class="font10">attention </span>
   <span class="font10">balance </span>
   <span class="font10">capsaicin </span>
   <span class="font10">cases. </span>
   <span class="font10">children. </span>
   <span class="font10">clearly </span>
   <span class="font10">considering </span>
   <span class="font10">consumption </span>
   <span class="font10">continuous </span>
   <span class="font10">cortex. </span>
   <span class="font10">dose, </span>
   <span class="font10">double-blind </span>
   <span class="font10">duration, </span>
   <span class="font10">estimates </span>
   <span class="font10">explain </span>
   <span class="font10">fact </span>
   <span class="font10">factors. </span>
   <span class="font10">frontal </span>
   <span class="font10">future </span>
   <span class="font10">includes </span>
   <span class="font10">increases </span>
   <span class="font10">infarction </span>
   <span class="font10">initial </span>
   <span class="font10">intensity. </span>
   <span class="font10">interaction </span>
   <span class="font10">ipsilateral </span>
   <span class="font10">knowledge </span>
   <span class="font10">lasmiditan </span>
   <span class="font10">learning </span>
   <span class="font10">menstrual </span>
   <span class="font10">metabolic </span>
   <span class="font10">methods: </span>
   <span class="font10">middle </span>
   <span class="font10">months, </span>
   <span class="font10">needs </span>
   <span class="font10">neurologic </span>
   <span class="font10">nutraceutical </span>
   <span class="font10">nutraceuticals </span>
   <span class="font10">onset. </span>
   <span class="font10">option </span>
   <span class="font10">outpatient </span>
   <span class="font10">particularly </span>
   <span class="font10">population-based </span>
   <span class="font10">position </span>
   <span class="font10">possibly </span>
   <span class="font10">practice </span>
   <span class="font10">pregnancy </span>
   <span class="font10">prospectively </span>
   <span class="font10">purpose </span>
   <span class="font10">questions </span>
   <span class="font10">real </span>
   <span class="font10">reduces </span>
   <span class="font10">reports </span>
   <span class="font10">requiring </span>
   <span class="font10">safe </span>
   <span class="font10">scan </span>
   <span class="font10">seizure </span>
   <span class="font10">significance </span>
   <span class="font10">sites </span>
   <span class="font10">state </span>
   <span class="font10">studied </span>
   <span class="font10">style </span>
   <span class="font10">subject </span>
   <span class="font10">substance </span>
   <span class="font10">suffered </span>
   <span class="font10">system. </span>
   <span class="font10">therapies. </span>
   <span class="font10">threshold </span>
   <span class="font10">transversal </span>
   <span class="font10">trial. </span>
   <span class="font10">triptans </span>
   <span class="font10">typically </span>
   <span class="font10">unilateral </span>
   <span class="font10">weeks. </span>
   <span class="font10">widespread </span>
   <span class="font10">years; </span>
   <span class="font10">young </span>
   <span class="font10">(range </span>
   <span class="font10">,). </span>
   <span class="font10">-day </span>
   <span class="font10">Affairs, </span>
   <span class="font10">Anna </span>
   <span class="font10">Ashina </span>
   <span class="font10">Bigal </span>
   <span class="font10">Biotechnology, </span>
   <span class="font10">Birmingham </span>
   <span class="font10">Carvalho </span>
   <span class="font10">Congress </span>
   <span class="font10">Curto </span>
   <span class="font10">Development, </span>
   <span class="font10">Division </span>
   <span class="font10">Don </span>
   <span class="font10">Frazer, </span>
   <span class="font10">Gianluca </span>
   <span class="font10">Here, </span>
   <span class="font10">ICHD </span>
   <span class="font10">Intracranial </span>
   <span class="font10">January </span>
   <span class="font10">King’s </span>
   <span class="font10">Mikol </span>
   <span class="font10">Modena </span>
   <span class="font10">Norwegian </span>
   <span class="font10">OnabotA </span>
   <span class="font10">Papetti </span>
   <span class="font10">Park </span>
   <span class="font10">Patient </span>
   <span class="font10">Questionnaire </span>
   <span class="font10">RB, </span>
   <span class="font10">Recent </span>
   <span class="font10">Referral </span>
   <span class="font10">Rehabilitation </span>
   <span class="font10">Reuter </span>
   <span class="font10">Rev </span>
   <span class="font10">SIH </span>
   <span class="font10">Simmaco </span>
   <span class="font10">State </span>
   <span class="font10">States </span>
   <span class="font10">Stovner </span>
   <span class="font10">Tommaso </span>
   <span class="font10">Torino, </span>
   <span class="font10">Trondheim, </span>
   <span class="font10">absence </span>
   <span class="font10">abstract </span>
   <span class="font10">activity, </span>
   <span class="font10">agreed </span>
   <span class="font10">air </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">appears </span>
   <span class="font10">appropriate </span>
   <span class="font10">approved </span>
   <span class="font10">basis </span>
   <span class="font10">behalf </span>
   <span class="font10">biomarkers </span>
   <span class="font10">branch </span>
   <span class="font10">capacity </span>
   <span class="font10">categories </span>
   <span class="font10">center </span>
   <span class="font10">cervicogenic </span>
   <span class="font10">component </span>
   <span class="font10">comprehensive </span>
   <span class="font10">condition. </span>
   <span class="font10">data. </span>
   <span class="font10">deficit </span>
   <span class="font10">definition </span>
   <span class="font10">delivered </span>
   <span class="font10">department </span>
   <span class="font10">design </span>
   <span class="font10">despite </span>
   <span class="font10">differential </span>
   <span class="font10">discomfort </span>
   <span class="font10">disease, </span>
   <span class="font10">distribution </span>
   <span class="font10">disturbances </span>
   <span class="font10">domains </span>
   <span class="font10">doses, </span>
   <span class="font10">educational </span>
   <span class="font10">endurance </span>
   <span class="font10">environmental </span>
   <span class="font10">epidural </span>
   <span class="font10">existing </span>
   <span class="font10">extension </span>
   <span class="font10">failed </span>
   <span class="font10">field </span>
   <span class="font10">findings. </span>
   <span class="font10">functioning </span>
   <span class="font10">however, </span>
   <span class="font10">hypothalamic </span>
   <span class="font10">induce </span>
   <span class="font10">influenced </span>
   <span class="font10">interictal </span>
   <span class="font10">ketogenic </span>
   <span class="font10">lateral </span>
   <span class="font10">lesions </span>
   <span class="font10">linear </span>
   <span class="font10">local </span>
   <span class="font10">lumbar </span>
   <span class="font10">maintained </span>
   <span class="font10">maximum </span>
   <span class="font10">meeting </span>
   <span class="font10">members </span>
   <span class="font10">met </span>
   <span class="font10">missed </span>
   <span class="font10">n=, </span>
   <span class="font10">neurophysiological </span>
   <span class="font10">noted </span>
   <span class="font10">nucleus </span>
   <span class="font10">p&amp;lt; </span>
   <span class="font10">pathophysiological </span>
   <span class="font10">patient’s </span>
   <span class="font10">phenomenon </span>
   <span class="font10">placebo-controlled, </span>
   <span class="font10">plc, </span>
   <span class="font10">practice. </span>
   <span class="font10">premonitory </span>
   <span class="font10">probable </span>
   <span class="font10">protein </span>
   <span class="font10">provides </span>
   <span class="font10">randomised, </span>
   <span class="font10">rarely </span>
   <span class="font10">rat </span>
   <span class="font10">real-life </span>
   <span class="font10">reason </span>
   <span class="font10">recommend </span>
   <span class="font10">remain </span>
   <span class="font10">resulting </span>
   <span class="font10">retrospectively </span>
   <span class="font10">root </span>
   <span class="font10">shared </span>
   <span class="font10">strategies </span>
   <span class="font10">stressful </span>
   <span class="font10">structures </span>
   <span class="font10">studies, </span>
   <span class="font10">surveys </span>
   <span class="font10">targeting </span>
   <span class="font10">techniques </span>
   <span class="font10">term </span>
   <span class="font10">test. </span>
   <span class="font10">therapy, </span>
   <span class="font10">usual </span>
   <span class="font10">validated </span>
   <span class="font10">way </span>
   <span class="font10">white </span>
   <span class="font10">with: </span>
   <span class="font10">worse </span>
   <span class="font10">(), </span>
   <span class="font10">(IHS). </span>
   <span class="font10">(both </span>
   <span class="font10">(n=). </span>
   <span class="font10">(p=.), </span>
   <span class="font10">(the </span>
   <span class="font10">;():–. </span>
   <span class="font10">A., </span>
   <span class="font10">Acute </span>
   <span class="font10">Adverse </span>
   <span class="font10">Alberto </span>
   <span class="font10">Aurora </span>
   <span class="font10">BMI </span>
   <span class="font10">Background. </span>
   <span class="font10">Bendtsen </span>
   <span class="font10">Carolei </span>
   <span class="font10">Cervical </span>
   <span class="font10">Changes </span>
   <span class="font10">Chapter </span>
   <span class="font10">Chiara </span>
   <span class="font10">Cincinnati </span>
   <span class="font10">Cohen </span>
   <span class="font10">Daniel </span>
   <span class="font10">Drug </span>
   <span class="font10">Female </span>
   <span class="font10">G.B. </span>
   <span class="font10">Giovanni </span>
   <span class="font10">Grazzi </span>
   <span class="font10">Group, </span>
   <span class="font10">HFDs </span>
   <span class="font10">III </span>
   <span class="font10">IRCCS, </span>
   <span class="font10">ISR-AEs </span>
   <span class="font10">Icco </span>
   <span class="font10">Joshua </span>
   <span class="font10">Kim </span>
   <span class="font10">Korea </span>
   <span class="font10">Lisotto </span>
   <span class="font10">ML, </span>
   <span class="font10">MPFID </span>
   <span class="font10">Matteo </span>
   <span class="font10">Migraine: </span>
   <span class="font10">Milan, </span>
   <span class="font10">Non-invasive </span>
   <span class="font10">Observation </span>
   <span class="font10">Olesen </span>
   <span class="font10">PJ, </span>
   <span class="font10">PJ. </span>
   <span class="font10">Pain, </span>
   <span class="font10">Parthenium, </span>
   <span class="font10">Peter </span>
   <span class="font10">PharmD, </span>
   <span class="font10">Pierelli </span>
   <span class="font10">Pistoia </span>
   <span class="font10">Placebo </span>
   <span class="font10">Preto </span>
   <span class="font10">Reggio </span>
   <span class="font10">Roberto </span>
   <span class="font10">Significant </span>
   <span class="font10">Stroke </span>
   <span class="font10">Survey </span>
   <span class="font10">Switzerland; </span>
   <span class="font10">Tanacetum </span>
   <span class="font10">Timothy </span>
   <span class="font10">Turin, </span>
   <span class="font10">Valentina </span>
   <span class="font10">Viana </span>
   <span class="font10">[monthly </span>
   <span class="font10">abnormal </span>
   <span class="font10">adequate </span>
   <span class="font10">adolescents. </span>
   <span class="font10">advice </span>
   <span class="font10">age: </span>
   <span class="font10">allow </span>
   <span class="font10">altered </span>
   <span class="font10">analysed </span>
   <span class="font10">approaches </span>
   <span class="font10">associations </span>
   <span class="font10">aura) </span>
   <span class="font10">avoidance </span>
   <span class="font10">awareness </span>
   <span class="font10">basic </span>
   <span class="font10">best </span>
   <span class="font10">bilateral </span>
   <span class="font10">blind </span>
   <span class="font10">carried </span>
   <span class="font10">cases, </span>
   <span class="font10">challenge </span>
   <span class="font10">conditions. </span>
   <span class="font10">consistent </span>
   <span class="font10">contact </span>
   <span class="font10">days); </span>
   <span class="font10">del </span>
   <span class="font10">delle </span>
   <span class="font10">disability, </span>
   <span class="font10">diseases, </span>
   <span class="font10">disorder, </span>
   <span class="font10">dizziness </span>
   <span class="font10">drugs, </span>
   <span class="font10">drugs. </span>
   <span class="font10">established </span>
   <span class="font10">events. </span>
   <span class="font10">evolution </span>
   <span class="font10">examination, </span>
   <span class="font10">excellent </span>
   <span class="font10">excluded </span>
   <span class="font10">extent </span>
   <span class="font10">fact, </span>
   <span class="font10">factors, </span>
   <span class="font10">far </span>
   <span class="font10">features. </span>
   <span class="font10">filled </span>
   <span class="font10">gender, </span>
   <span class="font10">herniation </span>
   <span class="font10">highlight </span>
   <span class="font10">hypothesis </span>
   <span class="font10">identification </span>
   <span class="font10">independent </span>
   <span class="font10">indicating </span>
   <span class="font10">intervention </span>
   <span class="font10">laboratory </span>
   <span class="font10">latency </span>
   <span class="font10">led </span>
   <span class="font10">little </span>
   <span class="font10">maternal </span>
   <span class="font10">max, </span>
   <span class="font10">means </span>
   <span class="font10">medicine </span>
   <span class="font10">method </span>
   <span class="font10">migraine-like </span>
   <span class="font10">migraine-specific </span>
   <span class="font10">minor </span>
   <span class="font10">module </span>
   <span class="font10">month, </span>
   <span class="font10">muscle </span>
   <span class="font10">neurogenic </span>
   <span class="font10">ng/ml </span>
   <span class="font10">non </span>
   <span class="font10">overuse. </span>
   <span class="font10">p&amp;lt;.), </span>
   <span class="font10">pain: </span>
   <span class="font10">pathological </span>
   <span class="font10">pathways </span>
   <span class="font10">patient, </span>
   <span class="font10">perception </span>
   <span class="font10">photophobia </span>
   <span class="font10">plus </span>
   <span class="font10">points, </span>
   <span class="font10">postural </span>
   <span class="font10">pregnancy, </span>
   <span class="font10">probably </span>
   <span class="font10">problem </span>
   <span class="font10">procedures </span>
   <span class="font10">processing </span>
   <span class="font10">produced </span>
   <span class="font10">prolonged </span>
   <span class="font10">receiving </span>
   <span class="font10">remains </span>
   <span class="font10">rest </span>
   <span class="font10">satisfaction </span>
   <span class="font10">setting </span>
   <span class="font10">short </span>
   <span class="font10">showing </span>
   <span class="font10">specialists </span>
   <span class="font10">specifically </span>
   <span class="font10">standardized </span>
   <span class="font10">stimuli </span>
   <span class="font10">subcortical </span>
   <span class="font10">suggesting </span>
   <span class="font10">tablet </span>
   <span class="font10">test, </span>
   <span class="font10">tomography </span>
   <span class="font10">transcranial </span>
   <span class="font10">variables </span>
   <span class="font10">vestibular </span>
   <span class="font10">volume </span>
   <span class="font10">widely </span>
   <span class="font10">women, </span>
   <span class="font10">women. </span>
   <span class="font10">≥%, </span>
   <span class="font10">%(n=) </span>
   <span class="font10">(%, </span>
   <span class="font10">(,) </span>
   <span class="font10">(.%, </span>
   <span class="font10">(Italy); </span>
   <span class="font10">(years) </span>
   <span class="font10">-year-old </span>
   <span class="font10">.±.) </span>
   <span class="font10">:–. </span>
   <span class="font10">AMSM </span>
   <span class="font10">Acupuncture </span>
   <span class="font10">Adams </span>
   <span class="font10">Andrea </span>
   <span class="font10">Andrew </span>
   <span class="font10">Anxiety </span>
   <span class="font10">Bari </span>
   <span class="font10">Battan </span>
   <span class="font10">Bietti </span>
   <span class="font10">Cerebral </span>
   <span class="font10">Clin </span>
   <span class="font10">ClinicalTrials.gov </span>
   <span class="font10">Competing </span>
   <span class="font10">Control </span>
   <span class="font10">Current </span>
   <span class="font10">Dach </span>
   <span class="font10">Division, </span>
   <span class="font10">Emilia, </span>
   <span class="font10">Experimental </span>
   <span class="font10">Facial </span>
   <span class="font10">Florencio </span>
   <span class="font10">Functional </span>
   <span class="font10">Gandhi </span>
   <span class="font10">General </span>
   <span class="font10">Gnocchi </span>
   <span class="font10">Guidetti </span>
   <span class="font10">Idiopathic </span>
   <span class="font10">Impairment </span>
   <span class="font10">Individuals </span>
   <span class="font10">Introduction </span>
   <span class="font10">Inventory </span>
   <span class="font10">Jefferson </span>
   <span class="font10">June </span>
   <span class="font10">Korean </span>
   <span class="font10">Lars </span>
   <span class="font10">Learning </span>
   <span class="font10">Liu </span>
   <span class="font10">Luigi </span>
   <span class="font10">MD, </span>
   <span class="font10">MSQoL </span>
   <span class="font10">Membrane </span>
   <span class="font10">Mitsikostas </span>
   <span class="font10">Modena, </span>
   <span class="font10">Neurologia </span>
   <span class="font10">Objectives: </span>
   <span class="font10">Overall, </span>
   <span class="font10">P=.; </span>
   <span class="font10">PED </span>
   <span class="font10">Potential </span>
   <span class="font10">Psychiatry, </span>
   <span class="font10">Sara </span>
   <span class="font10">Sarchielli </span>
   <span class="font10">Seoul, </span>
   <span class="font10">Spain; </span>
   <span class="font10">Statistical </span>
   <span class="font10">TRP </span>
   <span class="font10">Tension </span>
   <span class="font10">Tepper </span>
   <span class="font10">Topiramate </span>
   <span class="font10">Università </span>
   <span class="font10">VMR </span>
   <span class="font10">Vigevano </span>
   <span class="font10">Vincenzo </span>
   <span class="font10">Volta </span>
   <span class="font10">West </span>
   <span class="font10">Zhang </span>
   <span class="font10">access </span>
   <span class="font10">act </span>
   <span class="font10">actions </span>
   <span class="font10">added </span>
   <span class="font10">addition </span>
   <span class="font10">affects </span>
   <span class="font10">age. </span>
   <span class="font10">antagonist </span>
   <span class="font10">anti-CGRP </span>
   <span class="font10">arachnoidal </span>
   <span class="font10">auras </span>
   <span class="font10">behavior </span>
   <span class="font10">butterbur </span>
   <span class="font10">calculated </span>
   <span class="font10">cannabis </span>
   <span class="font10">causality </span>
   <span class="font10">centres </span>
   <span class="font10">cerebellum </span>
   <span class="font10">children, </span>
   <span class="font10">cold </span>
   <span class="font10">comorbidities. </span>
   <span class="font10">comparisons </span>
   <span class="font10">consider </span>
   <span class="font10">consultation </span>
   <span class="font10">contraceptives </span>
   <span class="font10">corpus </span>
   <span class="font10">criteria, </span>
   <span class="font10">damage </span>
   <span class="font10">date, </span>
   <span class="font10">days). </span>
   <span class="font10">debilitating </span>
   <span class="font10">depending </span>
   <span class="font10">designed </span>
   <span class="font10">detailed </span>
   <span class="font10">detection </span>
   <span class="font10">diagnosis, </span>
   <span class="font10">diffusion </span>
   <span class="font10">disease. </span>
   <span class="font10">diseases. </span>
   <span class="font10">electroCore, </span>
   <span class="font10">enhancement </span>
   <span class="font10">entry </span>
   <span class="font10">examine </span>
   <span class="font10">expert </span>
   <span class="font10">female, </span>
   <span class="font10">finding </span>
   <span class="font10">focused </span>
   <span class="font10">follow </span>
   <span class="font10">frequencies </span>
   <span class="font10">hoc </span>
   <span class="font10">hour </span>
   <span class="font10">hydroxy </span>
   <span class="font10">hypothyroidism </span>
   <span class="font10">implications </span>
   <span class="font10">improves </span>
   <span class="font10">invasive </span>
   <span class="font10">laminar </span>
   <span class="font10">leads </span>
   <span class="font10">life. </span>
   <span class="font10">link </span>
   <span class="font10">mechanisms. </span>
   <span class="font10">mg. </span>
   <span class="font10">migraineurs, </span>
   <span class="font10">monitoring </span>
   <span class="font10">monthly: </span>
   <span class="font10">motion </span>
   <span class="font10">motor </span>
   <span class="font10">multivariate </span>
   <span class="font10">nature </span>
   <span class="font10">necrosis </span>
   <span class="font10">online </span>
   <span class="font10">options </span>
   <span class="font10">p=.). </span>
   <span class="font10">paediatric </span>
   <span class="font10">parietal </span>
   <span class="font10">patterns </span>
   <span class="font10">performed. </span>
   <span class="font10">phases </span>
   <span class="font10">plantar </span>
   <span class="font10">pons </span>
   <span class="font10">possibility </span>
   <span class="font10">questionnaire. </span>
   <span class="font10">quite </span>
   <span class="font10">rapid </span>
   <span class="font10">rapidly </span>
   <span class="font10">rats </span>
   <span class="font10">reaction </span>
   <span class="font10">reasons </span>
   <span class="font10">recommended </span>
   <span class="font10">regions </span>
   <span class="font10">registry </span>
   <span class="font10">relapse </span>
   <span class="font10">restricted </span>
   <span class="font10">results. </span>
   <span class="font10">screened </span>
   <span class="font10">sequences </span>
   <span class="font10">session </span>
   <span class="font10">sex, </span>
   <span class="font10">sham, </span>
   <span class="font10">sinus. </span>
   <span class="font10">slight </span>
   <span class="font10">sphenopalatine </span>
   <span class="font10">stimulus </span>
   <span class="font10">stopped </span>
   <span class="font10">stress </span>
   <span class="font10">strong </span>
   <span class="font10">subgroups </span>
   <span class="font10">subscale </span>
   <span class="font10">subsequent </span>
   <span class="font10">surgical </span>
   <span class="font10">traditional </span>
   <span class="font10">white-matter </span>
   <span class="font10">woman </span>
   <span class="font10">yes </span>
   <span class="font10">"C. </span>
   <span class="font10">"Sapienza" </span>
   <span class="font10">&amp;gt;, </span>
   <span class="font10">(.%; </span>
   <span class="font10">(CM). </span>
   <span class="font10">(EM). </span>
   <span class="font10">(MRI) </span>
   <span class="font10">(OR=., </span>
   <span class="font10">(TTH) </span>
   <span class="font10">(from </span>
   <span class="font10">(nVNS, </span>
   <span class="font10">(quarterly: </span>
   <span class="font10">AM, </span>
   <span class="font10">Altered </span>
   <span class="font10">Aubrey </span>
   <span class="font10">Aurastop© </span>
   <span class="font10">Based </span>
   <span class="font10">Bilitou </span>
   <span class="font10">Bottiroli </span>
   <span class="font10">Brescia </span>
   <span class="font10">CNS </span>
   <span class="font10">Campus </span>
   <span class="font10">Capi </span>
   <span class="font10">Charité </span>
   <span class="font10">CoP </span>
   <span class="font10">David </span>
   <span class="font10">Dawn </span>
   <span class="font10">Development </span>
   <span class="font10">Different </span>
   <span class="font10">E., </span>
   <span class="font10">EM, </span>
   <span class="font10">Evangelista </span>
   <span class="font10">FU, </span>
   <span class="font10">Ferrante </span>
   <span class="font10">Ferrari </span>
   <span class="font10">Finally, </span>
   <span class="font10">Germany </span>
   <span class="font10">Giamberardino </span>
   <span class="font10">Giulia </span>
   <span class="font10">Giuseppe </span>
   <span class="font10">Guerzoni </span>
   <span class="font10">HCs </span>
   <span class="font10">Head </span>
   <span class="font10">Index </span>
   <span class="font10">Italy. </span>
   <span class="font10">J., </span>
   <span class="font10">KM, </span>
   <span class="font10">LLC </span>
   <span class="font10">LLC, </span>
   <span class="font10">Lampl </span>
   <span class="font10">MFIQ </span>
   <span class="font10">Margherita </span>
   <span class="font10">Mental </span>
   <span class="font10">Mian </span>
   <span class="font10">Michael </span>
   <span class="font10">Neurophthalmology, </span>
   <span class="font10">Pavia; </span>
   <span class="font10">Pellesi </span>
   <span class="font10">Peris </span>
   <span class="font10">Pinheiro </span>
   <span class="font10">Policlinico </span>
   <span class="font10">Pozzilli </span>
   <span class="font10">Preto-SP, </span>
   <span class="font10">Rep. </span>
   <span class="font10">Report </span>
   <span class="font10">Rigmor </span>
   <span class="font10">Roma, </span>
   <span class="font10">Sandrini </span>
   <span class="font10">Sanjay </span>
   <span class="font10">Sant'Andrea </span>
   <span class="font10">Section </span>
   <span class="font10">September </span>
   <span class="font10">Spreading </span>
   <span class="font10">Stefano </span>
   <span class="font10">Stewart </span>
   <span class="font10">Study. </span>
   <span class="font10">Summary </span>
   <span class="font10">Suppl </span>
   <span class="font10">Switzerland </span>
   <span class="font10">Tehran, </span>
   <span class="font10">Therapy </span>
   <span class="font10">Translational </span>
   <span class="font10">Type </span>
   <span class="font10">Uwe </span>
   <span class="font10">Viganò </span>
   <span class="font10">Vision </span>
   <span class="font10">Visual </span>
   <span class="font10">Vittorio </span>
   <span class="font10">Wilcoxon </span>
   <span class="font10">Winner </span>
   <span class="font10">World </span>
   <span class="font10">Zhao </span>
   <span class="font10">accuracy </span>
   <span class="font10">achieve </span>
   <span class="font10">addressed </span>
   <span class="font10">adjusted </span>
   <span class="font10">agreement </span>
   <span class="font10">alternative </span>
   <span class="font10">antimigraine </span>
   <span class="font10">approximately </span>
   <span class="font10">attack. </span>
   <span class="font10">atypical </span>
   <span class="font10">barrier </span>
   <span class="font10">behavioral </span>
   <span class="font10">calcium </span>
   <span class="font10">callosum </span>
   <span class="font10">characteristic </span>
   <span class="font10">children's </span>
   <span class="font10">complained </span>
   <span class="font10">components </span>
   <span class="font10">conclusion </span>
   <span class="font10">concomitant </span>
   <span class="font10">conditions, </span>
   <span class="font10">conservative </span>
   <span class="font10">continue </span>
   <span class="font10">contribute </span>
   <span class="font10">control, </span>
   <span class="font10">decision </span>
   <span class="font10">defect </span>
   <span class="font10">deficits </span>
   <span class="font10">define </span>
   <span class="font10">dental </span>
   <span class="font10">device. </span>
   <span class="font10">difficult </span>
   <span class="font10">disability. </span>
   <span class="font10">distinct </span>
   <span class="font10">dosage </span>
   <span class="font10">effects. </span>
   <span class="font10">electrical </span>
   <span class="font10">eligible </span>
   <span class="font10">essential </span>
   <span class="font10">exact </span>
   <span class="font10">experiences </span>
   <span class="font10">exposed </span>
   <span class="font10">face </span>
   <span class="font10">fear </span>
   <span class="font10">fremanezumab, </span>
   <span class="font10">granulations </span>
   <span class="font10">hand, </span>
   <span class="font10">headache-related </span>
   <span class="font10">headaches: </span>
   <span class="font10">healthcare </span>
   <span class="font10">highest </span>
   <span class="font10">i.e. </span>
   <span class="font10">identified. </span>
   <span class="font10">included. </span>
   <span class="font10">indicated </span>
   <span class="font10">inferior </span>
   <span class="font10">inflammation </span>
   <span class="font10">inflammatory </span>
   <span class="font10">investigating </span>
   <span class="font10">isopetasin, </span>
   <span class="font10">kg/m </span>
   <span class="font10">later </span>
   <span class="font10">leak </span>
   <span class="font10">load </span>
   <span class="font10">location </span>
   <span class="font10">logistic </span>
   <span class="font10">management: </span>
   <span class="font10">mediated </span>
   <span class="font10">metabolites </span>
   <span class="font10">mice </span>
   <span class="font10">microvascular </span>
   <span class="font10">nearly </span>
   <span class="font10">neuropeptide </span>
   <span class="font10">no. </span>
   <span class="font10">nociceptors </span>
   <span class="font10">non-invasive </span>
   <span class="font10">observations </span>
   <span class="font10">ones </span>
   <span class="font10">opening </span>
   <span class="font10">overuse, </span>
   <span class="font10">partial </span>
   <span class="font10">patient-reported </span>
   <span class="font10">perceived </span>
   <span class="font10">phenotypes </span>
   <span class="font10">presents </span>
   <span class="font10">problems </span>
   <span class="font10">profiles </span>
   <span class="font10">promising </span>
   <span class="font10">proper </span>
   <span class="font10">proportions </span>
   <span class="font10">providing </span>
   <span class="font10">px; </span>
   <span class="font10">ranging </span>
   <span class="font10">recovery </span>
   <span class="font10">reference </span>
   <span class="font10">representative </span>
   <span class="font10">represented </span>
   <span class="font10">respond </span>
   <span class="font10">scientific </span>
   <span class="font10">seconds </span>
   <span class="font10">sexual </span>
   <span class="font10">sham-controlled </span>
   <span class="font10">sildenafil </span>
   <span class="font10">software </span>
   <span class="font10">somatosensory </span>
   <span class="font10">splenial </span>
   <span class="font10">sponsored </span>
   <span class="font10">stroke. </span>
   <span class="font10">subjects, </span>
   <span class="font10">submitted </span>
   <span class="font10">supplementation </span>
   <span class="font10">surrounding </span>
   <span class="font10">susceptibility </span>
   <span class="font10">suspect </span>
   <span class="font10">systemic </span>
   <span class="font10">testing </span>
   <span class="font10">thalamic </span>
   <span class="font10">them, </span>
   <span class="font10">thought </span>
   <span class="font10">time, </span>
   <span class="font10">trained </span>
   <span class="font10">triggered </span>
   <span class="font10">triggers: </span>
   <span class="font10">variants </span>
   <span class="font10">verify </span>
   <span class="font10">version. </span>
   <span class="font10">visceral </span>
   <span class="font10">vomiting </span>
   <span class="font10">worldwide. </span>
   <span class="font10">{font-family </span>
   <span class="font10">–.±. </span>
   <span class="font10">‘protectors’ </span>
   <span class="font10">(Aurastop®) </span>
   <span class="font10">(CM), </span>
   <span class="font10">(IS), </span>
   <span class="font10">(MA) </span>
   <span class="font10">(Suppl </span>
   <span class="font10">(level </span>
   <span class="font10">.%). </span>
   <span class="font10">ASQ </span>
   <span class="font10">Allena </span>
   <span class="font10">American </span>
   <span class="font10">Amitriptyline </span>
   <span class="font10">Angela </span>
   <span class="font10">Anne </span>
   <span class="font10">Antonaci </span>
   <span class="font10">Aurastop® </span>
   <span class="font10">Available </span>
   <span class="font10">Average </span>
   <span class="font10">Avoidance </span>
   <span class="font10">Baseline= </span>
   <span class="font10">Basking </span>
   <span class="font10">Boucher </span>
   <span class="font10">Burden </span>
   <span class="font10">CDSS </span>
   <span class="font10">CI: </span>
   <span class="font10">CM-MO </span>
   <span class="font10">Chapel </span>
   <span class="font10">Claudia </span>
   <span class="font10">Complete </span>
   <span class="font10">Component </span>
   <span class="font10">DAVFs </span>
   <span class="font10">Dalla </span>
   <span class="font10">Dept. </span>
   <span class="font10">EM. </span>
   <span class="font10">Expression </span>
   <span class="font10">Fanning </span>
   <span class="font10">Ferreira </span>
   <span class="font10">Fitzgerald </span>
   <span class="font10">Funding </span>
   <span class="font10">Future </span>
   <span class="font10">GAD- </span>
   <span class="font10">GLP-R </span>
   <span class="font10">Gabriel </span>
   <span class="font10">Gabriela </span>
   <span class="font10">Gentile </span>
   <span class="font10">Glasgow, </span>
   <span class="font10">Griffonia </span>
   <span class="font10">Group. </span>
   <span class="font10">HC, </span>
   <span class="font10">Hagen </span>
   <span class="font10">Hanover, </span>
   <span class="font10">Healthcare </span>
   <span class="font10">Hernan </span>
   <span class="font10">Hill, </span>
   <span class="font10">ICHD-II </span>
   <span class="font10">IHS </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">Irene </span>
   <span class="font10">Juan </span>
   <span class="font10">Kapodistrian </span>
   <span class="font10">Laboratory </span>
   <span class="font10">Latina, </span>
   <span class="font10">Lidiane </span>
   <span class="font10">Liebler </span>
   <span class="font10">Linde </span>
   <span class="font10">Luana </span>
   <span class="font10">MMD </span>
   <span class="font10">MRI- </span>
   <span class="font10">MSQ </span>
   <span class="font10">Martina </span>
   <span class="font10">Mechanisms </span>
   <span class="font10">Meridian </span>
   <span class="font10">Methods. </span>
   <span class="font10">Migraine, </span>
   <span class="font10">Model </span>
   <span class="font10">Montefiore </span>
   <span class="font10">Monthly </span>
   <span class="font10">NCT. </span>
   <span class="font10">NHS </span>
   <span class="font10">Neuroimaging </span>
   <span class="font10">Novartis, </span>
   <span class="font10">November </span>
   <span class="font10">Number </span>
   <span class="font10">Objective </span>
   <span class="font10">Oliveira </span>
   <span class="font10">Onlus </span>
   <span class="font10">PCT </span>
   <span class="font10">Padua </span>
   <span class="font10">Peripheral </span>
   <span class="font10">Perugia, </span>
   <span class="font10">PhD </span>
   <span class="font10">Philadelphia, </span>
   <span class="font10">Picard </span>
   <span class="font10">Polo </span>
   <span class="font10">Preventive </span>
   <span class="font10">Productivity </span>
   <span class="font10">Prophylaxis </span>
   <span class="font10">Psychiatry </span>
   <span class="font10">Queensland, </span>
   <span class="font10">Rare </span>
   <span class="font10">Republic </span>
   <span class="font10">Ridge, </span>
   <span class="font10">Russo </span>
   <span class="font10">SD, </span>
   <span class="font10">SPSS </span>
   <span class="font10">Secondary </span>
   <span class="font10">Service </span>
   <span class="font10">Sinclair </span>
   <span class="font10">Spain </span>
   <span class="font10">Steiner </span>
   <span class="font10">Switzerland. </span>
   <span class="font10">TAS- </span>
   <span class="font10">TRN </span>
   <span class="font10">Tarantino </span>
   <span class="font10">Three-month </span>
   <span class="font10">TrPs </span>
   <span class="font10">Trust </span>
   <span class="font10">UOC </span>
   <span class="font10">Understanding </span>
   <span class="font10">Universitätsmedizin </span>
   <span class="font10">Use </span>
   <span class="font10">Using </span>
   <span class="font10">VAS </span>
   <span class="font10">VLCD </span>
   <span class="font10">Vedanta </span>
   <span class="font10">Venice, </span>
   <span class="font10">Vs. </span>
   <span class="font10">Women </span>
   <span class="font10">accompanied </span>
   <span class="font10">accurate </span>
   <span class="font10">actual </span>
   <span class="font10">admission </span>
   <span class="font10">admitted </span>
   <span class="font10">agonist, </span>
   <span class="font10">al, </span>
   <span class="font10">allowed </span>
   <span class="font10">amitriptyline </span>
   <span class="font10">analysis. </span>
   <span class="font10">analyze </span>
   <span class="font10">apnea </span>
   <span class="font10">area. </span>
   <span class="font10">artery </span>
   <span class="font10">assessment. </span>
   <span class="font10">average. </span>
   <span class="font10">basal </span>
   <span class="font10">benefits </span>
   <span class="font10">care. </span>
   <span class="font10">causing </span>
   <span class="font10">cell </span>
   <span class="font10">cerebrovascular </span>
   <span class="font10">certain </span>
   <span class="font10">chance </span>
   <span class="font10">channel </span>
   <span class="font10">characteristics. </span>
   <span class="font10">circulation </span>
   <span class="font10">classes </span>
   <span class="font10">closely </span>
   <span class="font10">complicated </span>
   <span class="font10">condition, </span>
   <span class="font10">consistently </span>
   <span class="font10">consisting </span>
   <span class="font10">consists </span>
   <span class="font10">contraceptive </span>
   <span class="font10">contribution </span>
   <span class="font10">convexity </span>
   <span class="font10">correct </span>
   <span class="font10">correlates </span>
   <span class="font10">corresponding </span>
   <span class="font10">critical </span>
   <span class="font10">cycles </span>
   <span class="font10">data, </span>
   <span class="font10">day, </span>
   <span class="font10">day. </span>
   <span class="font10">days), </span>
   <span class="font10">deep </span>
   <span class="font10">deficiency </span>
   <span class="font10">derived </span>
   <span class="font10">descriptive </span>
   <span class="font10">determined </span>
   <span class="font10">developing </span>
   <span class="font10">difficulty </span>
   <span class="font10">discuss </span>
   <span class="font10">double </span>
   <span class="font10">easily </span>
   <span class="font10">effects, </span>
   <span class="font10">efficient </span>
   <span class="font10">elderly </span>
   <span class="font10">endpoint </span>
   <span class="font10">endpoints </span>
   <span class="font10">event </span>
   <span class="font10">exacerbation </span>
   <span class="font10">examined </span>
   <span class="font10">experimental </span>
   <span class="font10">exploratory </span>
   <span class="font10">extracranial </span>
   <span class="font10">fixed </span>
   <span class="font10">flow </span>
   <span class="font10">focus </span>
   <span class="font10">font-size </span>
   <span class="font10">generalized </span>
   <span class="font10">gradual </span>
   <span class="font10">grey </span>
   <span class="font10">handicap </span>
   <span class="font10">headache-free </span>
   <span class="font10">hemicrania </span>
   <span class="font10">household </span>
   <span class="font10">identifying </span>
   <span class="font10">impaired </span>
   <span class="font10">inclusion </span>
   <span class="font10">individuals, </span>
   <span class="font10">induces </span>
   <span class="font10">ineffective </span>
   <span class="font10">inhibitory </span>
   <span class="font10">inhibits </span>
   <span class="font10">injection, </span>
   <span class="font10">intense </span>
   <span class="font10">interesting </span>
   <span class="font10">interval </span>
   <span class="font10">interviews </span>
   <span class="font10">intradural </span>
   <span class="font10">items </span>
   <span class="font10">joint </span>
   <span class="font10">kynurenine </span>
   <span class="font10">lifetime </span>
   <span class="font10">linked </span>
   <span class="font10">lived </span>
   <span class="font10">loss, </span>
   <span class="font10">marked </span>
   <span class="font10">mean±SD </span>
   <span class="font10">measurement </span>
   <span class="font10">measurements </span>
   <span class="font10">measures. </span>
   <span class="font10">mechanical </span>
   <span class="font10">medications. </span>
   <span class="font10">mg: </span>
   <span class="font10">min </span>
   <span class="font10">minutes. </span>
   <span class="font10">modulation </span>
   <span class="font10">multicentre </span>
   <span class="font10">musculoskeletal </span>
   <span class="font10">myofascial </span>
   <span class="font10">nasal </span>
   <span class="font10">nerves </span>
   <span class="font10">network </span>
   <span class="font10">networks </span>
   <span class="font10">neurologist </span>
   <span class="font10">neurovascular </span>
   <span class="font10">normal. </span>
   <span class="font10">normalization </span>
   <span class="font10">obese </span>
   <span class="font10">odds </span>
   <span class="font10">outcome. </span>
   <span class="font10">outcomes. </span>
   <span class="font10">p=,) </span>
   <span class="font10">p=,). </span>
   <span class="font10">parthenium </span>
   <span class="font10">participated </span>
   <span class="font10">participating </span>
   <span class="font10">patch </span>
   <span class="font10">peptide, </span>
   <span class="font10">peptidergic </span>
   <span class="font10">perfusion </span>
   <span class="font10">persistence </span>
   <span class="font10">persons </span>
   <span class="font10">physicians </span>
   <span class="font10">planned </span>
   <span class="font10">plc </span>
   <span class="font10">post-hoc </span>
   <span class="font10">potentials </span>
   <span class="font10">pre </span>
   <span class="font10">prescription </span>
   <span class="font10">presentation, </span>
   <span class="font10">primarily </span>
   <span class="font10">probiotic </span>
   <span class="font10">progression </span>
   <span class="font10">propose </span>
   <span class="font10">quantitative </span>
   <span class="font10">regimen </span>
   <span class="font10">region, </span>
   <span class="font10">regulation </span>
   <span class="font10">reliable </span>
   <span class="font10">remained </span>
   <span class="font10">resistant </span>
   <span class="font10">responsible </span>
   <span class="font10">retinal </span>
   <span class="font10">reviewed </span>
   <span class="font10">room </span>
   <span class="font10">safranal </span>
   <span class="font10">scores. </span>
   <span class="font10">screening </span>
   <span class="font10">search </span>
   <span class="font10">self-report </span>
   <span class="font10">share </span>
   <span class="font10">shift </span>
   <span class="font10">skin </span>
   <span class="font10">slope </span>
   <span class="font10">society </span>
   <span class="font10">sodium </span>
   <span class="font10">somatic </span>
   <span class="font10">source </span>
   <span class="font10">spectrum </span>
   <span class="font10">stimulations </span>
   <span class="font10">stop </span>
   <span class="font10">stroke: </span>
   <span class="font10">successful </span>
   <span class="font10">super-responders </span>
   <span class="font10">supporting </span>
   <span class="font10">sustained </span>
   <span class="font10">task </span>
   <span class="font10">team </span>
   <span class="font10">thrombophilic </span>
   <span class="font10">thyroid </span>
   <span class="font10">took </span>
   <span class="font10">transmission </span>
   <span class="font10">trend </span>
   <span class="font10">upper </span>
   <span class="font10">use. </span>
   <span class="font10">vagal </span>
   <span class="font10">variability </span>
   <span class="font10">vasoactive </span>
   <span class="font10">venous </span>
   <span class="font10">visit= </span>
   <span class="font10">visited </span>
   <span class="font10">visits, </span>
   <span class="font10">wall </span>
   <span class="font10">wave </span>
   <span class="font10">web-based </span>
   <span class="font10">worsen </span>
   <span class="font10">year. </span>
   <span class="font10">younger </span>
   <span class="font10">zingember </span>
   <span class="font10">−.), </span>
   <span class="font10">(&amp;gt; </span>
   <span class="font10">(-.; </span>
   <span class="font10">(.%); </span>
   <span class="font10">(Chadds </span>
   <span class="font10">(Dublin, </span>
   <span class="font10">(Group </span>
   <span class="font10">(MO) </span>
   <span class="font10">(age </span>
   <span class="font10">(and </span>
   <span class="font10">(e.g. </span>
   <span class="font10">(i.e. </span>
   <span class="font10">(i.e., </span>
   <span class="font10">(mean, </span>
   <span class="font10">(n=, </span>
   <span class="font10">(range) </span>
   <span class="font10">(–.±. </span>
   <span class="font10">,), </span>
   <span class="font10">,,, </span>
   <span class="font10">-., </span>
   <span class="font10">-EM </span>
   <span class="font10">-item </span>
   <span class="font10">-months </span>
   <span class="font10">.-.], </span>
   <span class="font10">;:- </span>
   <span class="font10">AHM </span>
   <span class="font10">AVM </span>
   <span class="font10">Abuse </span>
   <span class="font10">Acknowledgments </span>
   <span class="font10">Additionally, </span>
   <span class="font10">Aikaterini </span>
   <span class="font10">Alcohol </span>
   <span class="font10">Aldo </span>
   <span class="font10">Alec </span>
   <span class="font10">Amgen, </span>
   <span class="font10">Anesthesiology </span>
   <span class="font10">Attachment </span>
   <span class="font10">Aurastop </span>
   <span class="font10">Battan, </span>
   <span class="font10">Behavioural </span>
   <span class="font10">Biomechanics, </span>
   <span class="font10">Biotechnologies, </span>
   <span class="font10">Blood </span>
   <span class="font10">Brazil </span>
   <span class="font10">Brighina </span>
   <span class="font10">Bussone </span>
   <span class="font10">C., </span>
   <span class="font10">CHC </span>
   <span class="font10">CI, </span>
   <span class="font10">CaMEO </span>
   <span class="font10">Cady </span>
   <span class="font10">Cannabis </span>
   <span class="font10">Care </span>
   <span class="font10">Carina </span>
   <span class="font10">Centres </span>
   <span class="font10">Characteristics </span>
   <span class="font10">Chi-square </span>
   <span class="font10">Christian </span>
   <span class="font10">Cincinnati, </span>
   <span class="font10">Citta’ </span>
   <span class="font10">Città </span>
   <span class="font10">Clinico </span>
   <span class="font10">Communications, </span>
   <span class="font10">Comorbidities/Endophenotypes </span>
   <span class="font10">Cope </span>
   <span class="font10">Costa </span>
   <span class="font10">Cox </span>
   <span class="font10">DW, </span>
   <span class="font10">Degan </span>
   <span class="font10">Dept </span>
   <span class="font10">Diary </span>
   <span class="font10">Dizziness </span>
   <span class="font10">Domenico </span>
   <span class="font10">EHF </span>
   <span class="font10">Editorial </span>
   <span class="font10">Education </span>
   <span class="font10">Effect </span>
   <span class="font10">Eric </span>
   <span class="font10">Essen, </span>
   <span class="font10">Eurolight </span>
   <span class="font10">Fabiola </span>
   <span class="font10">Filippo </span>
   <span class="font10">Ford, </span>
   <span class="font10">France; </span>
   <span class="font10">Function </span>
   <span class="font10">GABAergic </span>
   <span class="font10">Gesu’ </span>
   <span class="font10">Gesù </span>
   <span class="font10">Given </span>
   <span class="font10">Glx </span>
   <span class="font10">Greater </span>
   <span class="font10">Groups </span>
   <span class="font10">HPTH </span>
   <span class="font10">HRU </span>
   <span class="font10">Hohaia, </span>
   <span class="font10">Hospitals </span>
   <span class="font10">Innsbruck, </span>
   <span class="font10">Ireland). </span>
   <span class="font10">Israel </span>
   <span class="font10">Klatt </span>
   <span class="font10">L., </span>
   <span class="font10">LCT </span>
   <span class="font10">LJ, </span>
   <span class="font10">LL, </span>
   <span class="font10">LOS </span>
   <span class="font10">Lainez </span>
   <span class="font10">Lancet </span>
   <span class="font10">Lanfranco </span>
   <span class="font10">Leone </span>
   <span class="font10">Locomotor </span>
   <span class="font10">MI, </span>
   <span class="font10">MO, </span>
   <span class="font10">MOH. </span>
   <span class="font10">Marcelo </span>
   <span class="font10">March </span>
   <span class="font10">Marina </span>
   <span class="font10">Maurizio </span>
   <span class="font10">Mayo </span>
   <span class="font10">Med. </span>
   <span class="font10">Medico-Surgical </span>
   <span class="font10">Migraine-Specific </span>
   <span class="font10">Migraine. </span>
   <span class="font10">Milan; </span>
   <span class="font10">Mindfulness </span>
   <span class="font10">NCT, </span>
   <span class="font10">NIHR-Wellcome </span>
   <span class="font10">NJ, </span>
   <span class="font10">NRS </span>
   <span class="font10">NSAIDs </span>
   <span class="font10">NVC </span>
   <span class="font10">Nat </span>
   <span class="font10">Nerve </span>
   <span class="font10">Neuralgia </span>
   <span class="font10">Neuromed, </span>
   <span class="font10">Neurosciences </span>
   <span class="font10">Nicoletti </span>
   <span class="font10">Objectives </span>
   <span class="font10">Onset </span>
   <span class="font10">Oral </span>
   <span class="font10">Ornello </span>
   <span class="font10">Oslo </span>
   <span class="font10">Oslo, </span>
   <span class="font10">Overall </span>
   <span class="font10">P&amp;lt;.), </span>
   <span class="font10">PA), </span>
   <span class="font10">PM, </span>
   <span class="font10">PR. </span>
   <span class="font10">Pablo </span>
   <span class="font10">Palm </span>
   <span class="font10">Panconesi </span>
   <span class="font10">Papetti, </span>
   <span class="font10">Parisi </span>
   <span class="font10">Parthenium </span>
   <span class="font10">Petolicchio </span>
   <span class="font10">Pharmacology </span>
   <span class="font10">Photophobia </span>
   <span class="font10">Pierangelo </span>
   <span class="font10">Pontino, </span>
   <span class="font10">Prieto </span>
   <span class="font10">Psychology </span>
   <span class="font10">Psychology, </span>
   <span class="font10">Public </span>
   <span class="font10">RESULTS: </span>
   <span class="font10">Reece </span>
   <span class="font10">Regina </span>
   <span class="font10">Rep </span>
   <span class="font10">Reproductive </span>
   <span class="font10">Retrospective </span>
   <span class="font10">Rigshospitalet-Glostrup, </span>
   <span class="font10">Roberta </span>
   <span class="font10">Role </span>
   <span class="font10">SJ, </span>
   <span class="font10">SK, </span>
   <span class="font10">SSDI </span>
   <span class="font10">STPP </span>
   <span class="font10">SUNCT </span>
   <span class="font10">Safety </span>
   <span class="font10">Salvatore </span>
   <span class="font10">Samuela </span>
   <span class="font10">Sexual </span>
   <span class="font10">Society, </span>
   <span class="font10">Society. </span>
   <span class="font10">Southern </span>
   <span class="font10">St. </span>
   <span class="font10">Stimulation </span>
   <span class="font10">Stroke. </span>
   <span class="font10">Studies </span>
   <span class="font10">Systems </span>
   <span class="font10">TH, </span>
   <span class="font10">TN, </span>
   <span class="font10">TTH, </span>
   <span class="font10">Technology, </span>
   <span class="font10">Tehran </span>
   <span class="font10">Termine </span>
   <span class="font10">The </span>
   <span class="font10">Trieste, </span>
   <span class="font10">Trigger </span>
   <span class="font10">Trust, </span>
   <span class="font10">Turkel </span>
   <span class="font10">Unfortunately, </span>
   <span class="font10">VLCKD </span>
   <span class="font10">Vagus </span>
   <span class="font10">Valeria </span>
   <span class="font10">Wang </span>
   <span class="font10">Wellness </span>
   <span class="font10">Work </span>
   <span class="font10">York, </span>
   <span class="font10">Young </span>
   <span class="font10">Zhou </span>
   <span class="font10">[%CI: </span>
   <span class="font10">[]; </span>
   <span class="font10">abortive </span>
   <span class="font10">abuse </span>
   <span class="font10">activated </span>
   <span class="font10">activities. </span>
   <span class="font10">adolescent </span>
   <span class="font10">afferent </span>
   <span class="font10">afferents </span>
   <span class="font10">agent </span>
   <span class="font10">ages </span>
   <span class="font10">aims </span>
   <span class="font10">antagonists </span>
   <span class="font10">anxiety" </span>
   <span class="font10">appeared </span>
   <span class="font10">appendix </span>
   <span class="font10">area, </span>
   <span class="font10">arteriovenous </span>
   <span class="font10">assessed. </span>
   <span class="font10">attack, </span>
   <span class="font10">attacks: </span>
   <span class="font10">availability </span>
   <span class="font10">baseline. </span>
   <span class="font10">baseline=. </span>
   <span class="font10">bed </span>
   <span class="font10">blinded </span>
   <span class="font10">blockade </span>
   <span class="font10">blurred </span>
   <span class="font10">brain. </span>
   <span class="font10">caloric </span>
   <span class="font10">campaign </span>
   <span class="font10">category </span>
   <span class="font10">causative </span>
   <span class="font10">cells </span>
   <span class="font10">characterize </span>
   <span class="font10">cholinergic </span>
   <span class="font10">chronification </span>
   <span class="font10">claims-based </span>
   <span class="font10">codified </span>
   <span class="font10">collaboration </span>
   <span class="font10">combinations </span>
   <span class="font10">comorbidity, </span>
   <span class="font10">company, </span>
   <span class="font10">complaint </span>
   <span class="font10">complementary </span>
   <span class="font10">conclusion, </span>
   <span class="font10">connectivity </span>
   <span class="font10">consequence </span>
   <span class="font10">contralateral </span>
   <span class="font10">contributes </span>
   <span class="font10">control. </span>
   <span class="font10">cord </span>
   <span class="font10">cross </span>
   <span class="font10">cutaneous </span>
   <span class="font10">demonstrate </span>
   <span class="font10">dependent </span>
   <span class="font10">deterioration </span>
   <span class="font10">diaries </span>
   <span class="font10">diet. </span>
   <span class="font10">discharged </span>
   <span class="font10">displacement </span>
   <span class="font10">disturbance </span>
   <span class="font10">double; </span>
   <span class="font10">draft </span>
   <span class="font10">employed </span>
   <span class="font10">endothelial </span>
   <span class="font10">equally </span>
   <span class="font10">establish </span>
   <span class="font10">estimate </span>
   <span class="font10">everyday </span>
   <span class="font10">evident </span>
   <span class="font10">exclude </span>
   <span class="font10">excursion </span>
   <span class="font10">extensor </span>
   <span class="font10">external </span>
   <span class="font10">extrapyramidal </span>
   <span class="font10">eyelid </span>
   <span class="font10">favour </span>
   <span class="font10">fluid. </span>
   <span class="font10">frequency. </span>
   <span class="font10">gain </span>
   <span class="font10">gammaCore </span>
   <span class="font10">gender </span>
   <span class="font10">generally </span>
   <span class="font10">genes </span>
   <span class="font10">glucose </span>
   <span class="font10">glymphatic </span>
   <span class="font10">groups: </span>
   <span class="font10">growing </span>
   <span class="font10">guide </span>
   <span class="font10">guidelines. </span>
   <span class="font10">habituation </span>
   <span class="font10">hemorrhage </span>
   <span class="font10">hyperexcitability </span>
   <span class="font10">identical </span>
   <span class="font10">illness </span>
   <span class="font10">images </span>
   <span class="font10">imaging, </span>
   <span class="font10">immediately </span>
   <span class="font10">immunogenicity </span>
   <span class="font10">infection, </span>
   <span class="font10">initiation </span>
   <span class="font10">injected </span>
   <span class="font10">inpatient </span>
   <span class="font10">insights </span>
   <span class="font10">interests </span>
   <span class="font10">interview </span>
   <span class="font10">intractable </span>
   <span class="font10">ischaemic </span>
   <span class="font10">isolated </span>
   <span class="font10">lacrimal </span>
   <span class="font10">largely </span>
   <span class="font10">localized </span>
   <span class="font10">males, </span>
   <span class="font10">management. </span>
   <span class="font10">manifestations </span>
   <span class="font10">mcg </span>
   <span class="font10">meaningful </span>
   <span class="font10">metacognitive </span>
   <span class="font10">mg), </span>
   <span class="font10">min, </span>
   <span class="font10">modified </span>
   <span class="font10">modulate </span>
   <span class="font10">molecules </span>
   <span class="font10">morphological </span>
   <span class="font10">nausea </span>
   <span class="font10">nausea, </span>
   <span class="font10">neurology </span>
   <span class="font10">neurostimulation </span>
   <span class="font10">non-headache </span>
   <span class="font10">non-pharmacological </span>
   <span class="font10">non-responders </span>
   <span class="font10">observed. </span>
   <span class="font10">oil </span>
   <span class="font10">one-year </span>
   <span class="font10">orthostatic </span>
   <span class="font10">outside </span>
   <span class="font10">overused </span>
   <span class="font10">oxygen </span>
   <span class="font10">palsy </span>
   <span class="font10">particular, </span>
   <span class="font10">pathology </span>
   <span class="font10">patients: </span>
   <span class="font10">patients; </span>
   <span class="font10">peak </span>
   <span class="font10">personal </span>
   <span class="font10">pharmacokinetic </span>
   <span class="font10">plasma </span>
   <span class="font10">pneumocephalus </span>
   <span class="font10">portion </span>
   <span class="font10">poster </span>
   <span class="font10">pre-existing </span>
   <span class="font10">pre-treatment </span>
   <span class="font10">preclinical </span>
   <span class="font10">prediction </span>
   <span class="font10">pregnant </span>
   <span class="font10">prevention. </span>
   <span class="font10">progressively </span>
   <span class="font10">propensity </span>
   <span class="font10">properties </span>
   <span class="font10">prospective, </span>
   <span class="font10">protective </span>
   <span class="font10">protector </span>
   <span class="font10">psychiatric, </span>
   <span class="font10">publish </span>
   <span class="font10">puncture. </span>
   <span class="font10">pure </span>
   <span class="font10">quality, </span>
   <span class="font10">quetiapine </span>
   <span class="font10">reaching </span>
   <span class="font10">receptors, </span>
   <span class="font10">recognized </span>
   <span class="font10">recovered </span>
   <span class="font10">reimbursable </span>
   <span class="font10">remaining </span>
   <span class="font10">requires </span>
   <span class="font10">research. </span>
   <span class="font10">responses. </span>
   <span class="font10">reverse </span>
   <span class="font10">samples </span>
   <span class="font10">scarce. </span>
   <span class="font10">school </span>
   <span class="font10">section, </span>
   <span class="font10">self-administered </span>
   <span class="font10">sent </span>
   <span class="font10">separate </span>
   <span class="font10">sessions </span>
   <span class="font10">setting. </span>
   <span class="font10">sharing </span>
   <span class="font10">short-lasting </span>
   <span class="font10">simple </span>
   <span class="font10">simulation </span>
   <span class="font10">slightly </span>
   <span class="font10">stabbing </span>
   <span class="font10">started. </span>
   <span class="font10">step </span>
   <span class="font10">strategy </span>
   <span class="font10">studying </span>
   <span class="font10">subclinical </span>
   <span class="font10">substantially </span>
   <span class="font10">sudden </span>
   <span class="font10">suggestive </span>
   <span class="font10">supplements </span>
   <span class="font10">supraorbital </span>
   <span class="font10">surgery </span>
   <span class="font10">systematically </span>
   <span class="font10">tend </span>
   <span class="font10">trait </span>
   <span class="font10">transition </span>
   <span class="font10">trauma </span>
   <span class="font10">trauma, </span>
   <span class="font10">traumas </span>
   <span class="font10">treating </span>
   <span class="font10">triggering </span>
   <span class="font10">triggers, </span>
   <span class="font10">triggers. </span>
   <span class="font10">tumor </span>
   <span class="font10">twice </span>
   <span class="font10">uncommon </span>
   <span class="font10">undiagnosed </span>
   <span class="font10">unmutated </span>
   <span class="font10">unnecessary </span>
   <span class="font10">usage </span>
   <span class="font10">utilization </span>
   <span class="font10">valid </span>
   <span class="font10">van </span>
   <span class="font10">vanilloid </span>
   <span class="font10">variations </span>
   <span class="font10">vegetative </span>
   <span class="font10">vertigo </span>
   <span class="font10">waves </span>
   <span class="font10">working </span>
   <span class="font10">years), </span>
   <span class="font10">%), </span>
   <span class="font10">%CI </span>
   <span class="font10">&amp;gt;% </span>
   <span class="font10">():. </span>
   <span class="font10">(.), </span>
   <span class="font10">(.; </span>
   <span class="font10">(BoNT-A: </span>
   <span class="font10">(CH) </span>
   <span class="font10">(CPH) </span>
   <span class="font10">(Curelator </span>
   <span class="font10">(F: </span>
   <span class="font10">(Headache </span>
   <span class="font10">(IIH) </span>
   <span class="font10">(IQR </span>
   <span class="font10">(M) </span>
   <span class="font10">(MIDAS) </span>
   <span class="font10">(NE, </span>
   <span class="font10">(Richard.Lipton@einstein.yu.edu) </span>
   <span class="font10">(ds </span>
   <span class="font10">(including </span>
   <span class="font10">(mg: </span>
   <span class="font10">(n, </span>
   <span class="font10">(nVNS) </span>
   <span class="font10">(onabotulinumtoxinA, </span>
   <span class="font10">(p&amp;gt;.). </span>
   <span class="font10">(pain </span>
   <span class="font10">(pamela.vo@novartis.com) </span>
   <span class="font10">(simona.sacco@univaq.it) </span>
   <span class="font10">*p&amp;lt;. </span>
   <span class="font10">,(,) </span>
   <span class="font10">-%, </span>
   <span class="font10">-hydroxy </span>
   <span class="font10">.±.). </span>
   <span class="font10">:-: </span>
   <span class="font10">AC, </span>
   <span class="font10">ACT, </span>
   <span class="font10">AS, </span>
   <span class="font10">Aalborg </span>
   <span class="font10">Aalborg, </span>
   <span class="font10">Activity </span>
   <span class="font10">Adults </span>
   <span class="font10">Annalisa </span>
   <span class="font10">App </span>
   <span class="font10">April </span>
   <span class="font10">Austria; </span>
   <span class="font10">BONTA </span>
   <span class="font10">Besta" </span>
   <span class="font10">Biomedical </span>
   <span class="font10">Brandes </span>
   <span class="font10">Brazil; </span>
   <span class="font10">Burstein </span>
   <span class="font10">CBD </span>
   <span class="font10">CD, </span>
   <span class="font10">CH. </span>
   <span class="font10">CMWPCs </span>
   <span class="font10">CONCLUSIONS: </span>
   <span class="font10">CVST </span>
   <span class="font10">Calabresi </span>
   <span class="font10">Calcitonin </span>
   <span class="font10">Cambridge, </span>
   <span class="font10">Careggi </span>
   <span class="font10">Carlos </span>
   <span class="font10">Central </span>
   <span class="font10">Centre. </span>
   <span class="font10">Cerebrospinal </span>
   <span class="font10">Cervicogenic </span>
   <span class="font10">Cheng </span>
   <span class="font10">Cho </span>
   <span class="font10">Combined </span>
   <span class="font10">Conflicts </span>
   <span class="font10">Consortium </span>
   <span class="font10">Corbelli </span>
   <span class="font10">Cristiano </span>
   <span class="font10">Criteria </span>
   <span class="font10">Czech </span>
   <span class="font10">D., </span>
   <span class="font10">DBS </span>
   <span class="font10">Dartmouth, </span>
   <span class="font10">December </span>
   <span class="font10">Detoxification </span>
   <span class="font10">Diabetes </span>
   <span class="font10">Dipartimento </span>
   <span class="font10">Discussion </span>
   <span class="font10">Discussion: </span>
   <span class="font10">Disease </span>
   <span class="font10">Dong </span>
   <span class="font10">Duration </span>
   <span class="font10">Early </span>
   <span class="font10">Effectiveness </span>
   <span class="font10">Eli </span>
   <span class="font10">Elisa </span>
   <span class="font10">Emanuele </span>
   <span class="font10">Endocrinology </span>
   <span class="font10">Endocrinology, </span>
   <span class="font10">Europe </span>
   <span class="font10">Europe. </span>
   <span class="font10">Evidence </span>
   <span class="font10">Evidera, </span>
   <span class="font10">Exclusion </span>
   <span class="font10">Facility, </span>
   <span class="font10">Falla </span>
   <span class="font10">Fazio </span>
   <span class="font10">Females </span>
   <span class="font10">Feng </span>
   <span class="font10">Foundation; </span>
   <span class="font10">Frequency </span>
   <span class="font10">Geisel </span>
   <span class="font10">Germany, </span>
   <span class="font10">Ghiotto </span>
   <span class="font10">Greece </span>
   <span class="font10">Grosberg </span>
   <span class="font10">Hans-Christoph </span>
   <span class="font10">Headache: </span>
   <span class="font10">ICP. </span>
   <span class="font10">Increased </span>
   <span class="font10">Innocenzo </span>
   <span class="font10">JL, </span>
   <span class="font10">Keywords: </span>
   <span class="font10">Kristina </span>
   <span class="font10">Kurth </span>
   <span class="font10">LA, </span>
   <span class="font10">Lenola </span>
   <span class="font10">Lenz </span>
   <span class="font10">Leonardi </span>
   <span class="font10">Lifting </span>
   <span class="font10">Long </span>
   <span class="font10">Lupi </span>
   <span class="font10">MBB </span>
   <span class="font10">METHODS: </span>
   <span class="font10">MF. </span>
   <span class="font10">MMA </span>
   <span class="font10">MOH, </span>
   <span class="font10">MWA </span>
   <span class="font10">Main </span>
   <span class="font10">Management </span>
   <span class="font10">Marta </span>
   <span class="font10">Materazzi </span>
   <span class="font10">Med </span>
   <span class="font10">Medical, </span>
   <span class="font10">Medication-overuse </span>
   <span class="font10">Merlo </span>
   <span class="font10">Messoud </span>
   <span class="font10">Metabolism </span>
   <span class="font10">Ministry </span>
   <span class="font10">Months </span>
   <span class="font10">Moro </span>
   <span class="font10">Moscow, </span>
   <span class="font10">N-P </span>
   <span class="font10">NE) </span>
   <span class="font10">NH, </span>
   <span class="font10">Nashville </span>
   <span class="font10">Nashville, </span>
   <span class="font10">Natascia </span>
   <span class="font10">Nausea </span>
   <span class="font10">Neurologico </span>
   <span class="font10">Neurosci. </span>
   <span class="font10">Neurosurg </span>
   <span class="font10">Neurosurgery, </span>
   <span class="font10">Nicola </span>
   <span class="font10">Nicolodi </span>
   <span class="font10">Norway </span>
   <span class="font10">Nutraceuticals </span>
   <span class="font10">O). </span>
   <span class="font10">Objective: </span>
   <span class="font10">October </span>
   <span class="font10">Olavs </span>
   <span class="font10">Onabotulinumtoxin </span>
   <span class="font10">Oncology, </span>
   <span class="font10">Opin </span>
   <span class="font10">P-value </span>
   <span class="font10">PA, </span>
   <span class="font10">PACAP- </span>
   <span class="font10">PHC </span>
   <span class="font10">PHQ- </span>
   <span class="font10">PSQI </span>
   <span class="font10">Padova, </span>
   <span class="font10">Paemeleire </span>
   <span class="font10">Parthenolide </span>
   <span class="font10">Pearson’s </span>
   <span class="font10">PhD, </span>
   <span class="font10">Prevention </span>
   <span class="font10">Prudenzano </span>
   <span class="font10">Psychological </span>
   <span class="font10">Puma </span>
   <span class="font10">Qin </span>
   <span class="font10">QoL </span>
   <span class="font10">RB. </span>
   <span class="font10">RG: </span>
   <span class="font10">RH, </span>
   <span class="font10">Raffaele </span>
   <span class="font10">Receptor </span>
   <span class="font10">Refractory </span>
   <span class="font10">Republic; </span>
   <span class="font10">Respondents </span>
   <span class="font10">Reversible </span>
   <span class="font10">Rigshospitalet </span>
   <span class="font10">Rigshospitalet, </span>
   <span class="font10">Rossi </span>
   <span class="font10">Ruiz </span>
   <span class="font10">Russia; </span>
   <span class="font10">S., </span>
   <span class="font10">SD) </span>
   <span class="font10">SF- </span>
   <span class="font10">SIFI </span>
   <span class="font10">SISC </span>
   <span class="font10">SPG </span>
   <span class="font10">Salute </span>
   <span class="font10">Sample </span>
   <span class="font10">Savi </span>
   <span class="font10">Schwedt </span>
   <span class="font10">Sci </span>
   <span class="font10">Score </span>
   <span class="font10">Sensory </span>
   <span class="font10">Serrano </span>
   <span class="font10">Services </span>
   <span class="font10">Sex </span>
   <span class="font10">Sham </span>
   <span class="font10">South </span>
   <span class="font10">Sphenopalatine </span>
   <span class="font10">Spontaneous </span>
   <span class="font10">Studio </span>
   <span class="font10">Symptomatic </span>
   <span class="font10">Systematic </span>
   <span class="font10">T-weighted </span>
   <span class="font10">TACs </span>
   <span class="font10">TJ, </span>
   <span class="font10">TN. </span>
   <span class="font10">Tension-Type </span>
   <span class="font10">Teva, </span>
   <span class="font10">Therapy, </span>
   <span class="font10">Thus, </span>
   <span class="font10">Tiseo </span>
   <span class="font10">Togha </span>
   <span class="font10">Toldo </span>
   <span class="font10">Trait </span>
   <span class="font10">Trendelenburg </span>
   <span class="font10">Vernieri </span>
   <span class="font10">Vigevano, </span>
   <span class="font10">Vincent </span>
   <span class="font10">Vito </span>
   <span class="font10">Withdrawn </span>
   <span class="font10">absolute </span>
   <span class="font10">absorption </span>
   <span class="font10">accessible </span>
   <span class="font10">accordingly </span>
   <span class="font10">account </span>
   <span class="font10">activity. </span>
   <span class="font10">add-on </span>
   <span class="font10">adenylate </span>
   <span class="font10">advisory </span>
   <span class="font10">age±SD </span>
   <span class="font10">aggravation </span>
   <span class="font10">allows </span>
   <span class="font10">alteration </span>
   <span class="font10">analogue </span>
   <span class="font10">analyses, </span>
   <span class="font10">analysis, </span>
   <span class="font10">anatomical </span>
   <span class="font10">antidepressants </span>
   <span class="font10">aphasia </span>
   <span class="font10">approach. </span>
   <span class="font10">arm </span>
   <span class="font10">articles </span>
   <span class="font10">attempt </span>
   <span class="font10">attending </span>
   <span class="font10">autoimmune </span>
   <span class="font10">behavior. </span>
   <span class="font10">behavioural </span>
   <span class="font10">benign </span>
   <span class="font10">biological </span>
   <span class="font10">bipolar </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">burden, </span>
   <span class="font10">burden. </span>
   <span class="font10">came </span>
   <span class="font10">care, </span>
   <span class="font10">caregivers </span>
   <span class="font10">carry </span>
   <span class="font10">case, </span>
   <span class="font10">case-control </span>
   <span class="font10">categories. </span>
   <span class="font10">cause. </span>
   <span class="font10">centers </span>
   <span class="font10">challenging </span>
   <span class="font10">changing </span>
   <span class="font10">child </span>
   <span class="font10">choroid </span>
   <span class="font10">chromatic </span>
   <span class="font10">classifications </span>
   <span class="font10">classify </span>
   <span class="font10">clinic, </span>
   <span class="font10">clinician </span>
   <span class="font10">clinicians </span>
   <span class="font10">clinics </span>
   <span class="font10">collect </span>
   <span class="font10">composed </span>
   <span class="font10">compounds </span>
   <span class="font10">concept </span>
   <span class="font10">concerning </span>
   <span class="font10">conducted. </span>
   <span class="font10">conjunctival </span>
   <span class="font10">connective </span>
   <span class="font10">consecutively </span>
   <span class="font10">contrary, </span>
   <span class="font10">contrast </span>
   <span class="font10">contributing </span>
   <span class="font10">controlling </span>
   <span class="font10">controls, </span>
   <span class="font10">cough </span>
   <span class="font10">counselling </span>
   <span class="font10">countries. </span>
   <span class="font10">covariance </span>
   <span class="font10">crisis </span>
   <span class="font10">cross-over </span>
   <span class="font10">curves </span>
   <span class="font10">database </span>
   <span class="font10">days/month, </span>
   <span class="font10">days/month. </span>
   <span class="font10">decoction </span>
   <span class="font10">defect, </span>
   <span class="font10">definitions </span>
   <span class="font10">demographic </span>
   <span class="font10">demonstrating </span>
   <span class="font10">describes </span>
   <span class="font10">detected. </span>
   <span class="font10">detecting </span>
   <span class="font10">determining </span>
   <span class="font10">deviation </span>
   <span class="font10">diary. </span>
   <span class="font10">diet, </span>
   <span class="font10">differed </span>
   <span class="font10">dilatation </span>
   <span class="font10">dilation </span>
   <span class="font10">directions </span>
   <span class="font10">discussed </span>
   <span class="font10">discussed. </span>
   <span class="font10">disorder. </span>
   <span class="font10">disturbances. </span>
   <span class="font10">dizziness, </span>
   <span class="font10">dorsal </span>
   <span class="font10">dramatic </span>
   <span class="font10">drop </span>
   <span class="font10">dura </span>
   <span class="font10">duration. </span>
   <span class="font10">eCH </span>
   <span class="font10">edition, </span>
   <span class="font10">edition. </span>
   <span class="font10">emerged </span>
   <span class="font10">enables </span>
   <span class="font10">endpoint, </span>
   <span class="font10">enrolled. </span>
   <span class="font10">ensure </span>
   <span class="font10">entered </span>
   <span class="font10">epidemiologic </span>
   <span class="font10">episode </span>
   <span class="font10">erenumab, </span>
   <span class="font10">erenumab. </span>
   <span class="font10">etiology </span>
   <span class="font10">evidences </span>
   <span class="font10">examination. </span>
   <span class="font10">example, </span>
   <span class="font10">excessive </span>
   <span class="font10">executive </span>
   <span class="font10">exercise </span>
   <span class="font10">existence </span>
   <span class="font10">expected </span>
   <span class="font10">experiments </span>
   <span class="font10">explaining </span>
   <span class="font10">fibromyalgia </span>
   <span class="font10">field, </span>
   <span class="font10">follow-up, </span>
   <span class="font10">followed-up </span>
   <span class="font10">food </span>
   <span class="font10">formulation </span>
   <span class="font10">fremanuzemab </span>
   <span class="font10">function, </span>
   <span class="font10">functions </span>
   <span class="font10">gastrointestinal </span>
   <span class="font10">gave </span>
   <span class="font10">genome-wide </span>
   <span class="font10">gradually </span>
   <span class="font10">guideline </span>
   <span class="font10">gyrus </span>
   <span class="font10">hand </span>
   <span class="font10">heart </span>
   <span class="font10">hemiplegic </span>
   <span class="font10">highlights </span>
   <span class="font10">history, </span>
   <span class="font10">home </span>
   <span class="font10">hormone </span>
   <span class="font10">hospitalized </span>
   <span class="font10">hours, </span>
   <span class="font10">hours. </span>
   <span class="font10">hypotheses </span>
   <span class="font10">imbalance </span>
   <span class="font10">immune </span>
   <span class="font10">improving </span>
   <span class="font10">inadequate </span>
   <span class="font10">indicates </span>
   <span class="font10">infarction. </span>
   <span class="font10">infection </span>
   <span class="font10">inhibit </span>
   <span class="font10">injection. </span>
   <span class="font10">injuries </span>
   <span class="font10">instructed </span>
   <span class="font10">insufficient </span>
   <span class="font10">interest. </span>
   <span class="font10">intermedius </span>
   <span class="font10">interpretation </span>
   <span class="font10">intravenous </span>
   <span class="font10">investigated. </span>
   <span class="font10">involving </span>
   <span class="font10">isopetasin </span>
   <span class="font10">issue </span>
   <span class="font10">issues </span>
   <span class="font10">lag, </span>
   <span class="font10">lasted </span>
   <span class="font10">leg </span>
   <span class="font10">level, </span>
   <span class="font10">lidocaine </span>
   <span class="font10">ligand, </span>
   <span class="font10">line </span>
   <span class="font10">list </span>
   <span class="font10">literature, </span>
   <span class="font10">literature. </span>
   <span class="font10">lost </span>
   <span class="font10">lowered </span>
   <span class="font10">making </span>
   <span class="font10">maps </span>
   <span class="font10">marker </span>
   <span class="font10">masticatory </span>
   <span class="font10">matching </span>
   <span class="font10">medication. </span>
   <span class="font10">membrane </span>
   <span class="font10">men. </span>
   <span class="font10">metabolism </span>
   <span class="font10">methods. </span>
   <span class="font10">migraine-free </span>
   <span class="font10">migraine-related </span>
   <span class="font10">migraine; </span>
   <span class="font10">missing </span>
   <span class="font10">modelled </span>
   <span class="font10">modify </span>
   <span class="font10">modulates </span>
   <span class="font10">morphometry </span>
   <span class="font10">mothers’ </span>
   <span class="font10">mouse </span>
   <span class="font10">movement </span>
   <span class="font10">mutation </span>
   <span class="font10">named </span>
   <span class="font10">near </span>
   <span class="font10">negatively </span>
   <span class="font10">neuralgiform </span>
   <span class="font10">neuromodulation </span>
   <span class="font10">neurons. </span>
   <span class="font10">neuropathy </span>
   <span class="font10">neuropeptides </span>
   <span class="font10">neurosteroids </span>
   <span class="font10">neurotransmitter </span>
   <span class="font10">nitroglycerin-induced </span>
   <span class="font10">normal, </span>
   <span class="font10">numbers </span>
   <span class="font10">obtain </span>
   <span class="font10">occlusion </span>
   <span class="font10">old) </span>
   <span class="font10">onabotulinumtoxin </span>
   <span class="font10">ongoing </span>
   <span class="font10">optic </span>
   <span class="font10">original </span>
   <span class="font10">orofacial </span>
   <span class="font10">p&amp;lt;.] </span>
   <span class="font10">p-values </span>
   <span class="font10">pain) </span>
   <span class="font10">pain-free </span>
   <span class="font10">pains </span>
   <span class="font10">paired </span>
   <span class="font10">panel </span>
   <span class="font10">paracetamol </span>
   <span class="font10">parallel-group </span>
   <span class="font10">participate </span>
   <span class="font10">pathophysiologic </span>
   <span class="font10">patients) </span>
   <span class="font10">people, </span>
   <span class="font10">percent </span>
   <span class="font10">perform </span>
   <span class="font10">performance. </span>
   <span class="font10">perspective </span>
   <span class="font10">phase. </span>
   <span class="font10">phenomena </span>
   <span class="font10">phenotype </span>
   <span class="font10">photophobia. </span>
   <span class="font10">phytotherapic </span>
   <span class="font10">pituitary </span>
   <span class="font10">placebo: </span>
   <span class="font10">plays </span>
   <span class="font10">plots </span>
   <span class="font10">pointed </span>
   <span class="font10">points) </span>
   <span class="font10">pontine </span>
   <span class="font10">population) </span>
   <span class="font10">population). </span>
   <span class="font10">populations </span>
   <span class="font10">positively </span>
   <span class="font10">postcontrast </span>
   <span class="font10">practices </span>
   <span class="font10">practitioner </span>
   <span class="font10">preceding </span>
   <span class="font10">precise </span>
   <span class="font10">predict </span>
   <span class="font10">prefrontal </span>
   <span class="font10">present, </span>
   <span class="font10">press. </span>
   <span class="font10">private </span>
   <span class="font10">products </span>
   <span class="font10">professional </span>
   <span class="font10">project </span>
   <span class="font10">propagation </span>
   <span class="font10">properly </span>
   <span class="font10">proposed. </span>
   <span class="font10">protectors </span>
   <span class="font10">proven </span>
   <span class="font10">ptosis </span>
   <span class="font10">questionnaire, </span>
   <span class="font10">quota </span>
   <span class="font10">raised </span>
   <span class="font10">ranges </span>
   <span class="font10">rating </span>
   <span class="font10">reached </span>
   <span class="font10">reactivity </span>
   <span class="font10">receptor. </span>
   <span class="font10">recommendations. </span>
   <span class="font10">record </span>
   <span class="font10">red </span>
   <span class="font10">regard </span>
   <span class="font10">regarded </span>
   <span class="font10">relationships </span>
   <span class="font10">relatively </span>
   <span class="font10">remarkable </span>
   <span class="font10">request </span>
   <span class="font10">required </span>
   <span class="font10">resistance </span>
   <span class="font10">responded </span>
   <span class="font10">rest, </span>
   <span class="font10">reversible </span>
   <span class="font10">reviewed. </span>
   <span class="font10">revised </span>
   <span class="font10">risks </span>
   <span class="font10">rodents </span>
   <span class="font10">role. </span>
   <span class="font10">sampling </span>
   <span class="font10">scales. </span>
   <span class="font10">scans </span>
   <span class="font10">scored </span>
   <span class="font10">scores, </span>
   <span class="font10">secretion </span>
   <span class="font10">sensitivity, </span>
   <span class="font10">simultaneous </span>
   <span class="font10">size </span>
   <span class="font10">sleep, </span>
   <span class="font10">snow </span>
   <span class="font10">solid; </span>
   <span class="font10">special </span>
   <span class="font10">specialized </span>
   <span class="font10">specially </span>
   <span class="font10">stable </span>
   <span class="font10">stages </span>
   <span class="font10">start </span>
   <span class="font10">statement </span>
   <span class="font10">status. </span>
   <span class="font10">steroids </span>
   <span class="font10">strict </span>
   <span class="font10">stroke, </span>
   <span class="font10">strongly </span>
   <span class="font10">subarachnoid </span>
   <span class="font10">subtypes </span>
   <span class="font10">suffers </span>
   <span class="font10">sumatriptan </span>
   <span class="font10">symptom, </span>
   <span class="font10">syndrome, </span>
   <span class="font10">syndromes </span>
   <span class="font10">systems </span>
   <span class="font10">tailored </span>
   <span class="font10">telephone </span>
   <span class="font10">temporomandibular </span>
   <span class="font10">tests, </span>
   <span class="font10">thalamus </span>
   <span class="font10">them. </span>
   <span class="font10">therapies, </span>
   <span class="font10">thunderclap </span>
   <span class="font10">tolerated </span>
   <span class="font10">tone </span>
   <span class="font10">topiramate. </span>
   <span class="font10">topographical </span>
   <span class="font10">tract </span>
   <span class="font10">trauma. </span>
   <span class="font10">trials, </span>
   <span class="font10">tried </span>
   <span class="font10">true </span>
   <span class="font10">unclear </span>
   <span class="font10">undergoing </span>
   <span class="font10">unknown. </span>
   <span class="font10">unmet </span>
   <span class="font10">unusual </span>
   <span class="font10">updated </span>
   <span class="font10">urinary </span>
   <span class="font10">user </span>
   <span class="font10">validity </span>
   <span class="font10">variation </span>
   <span class="font10">vasculature </span>
   <span class="font10">velocity </span>
   <span class="font10">version) </span>
   <span class="font10">vessels </span>
   <span class="font10">view </span>
   <span class="font10">vision </span>
   <span class="font10">volumetric </span>
   <span class="font10">von </span>
   <span class="font10">waiting </span>
   <span class="font10">website </span>
   <span class="font10">well-tolerated </span>
   <span class="font10">wider </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10"> AUC </span>
   <span class="font10">–.%±.%, </span>
   <span class="font10">"Berkson’s </span>
   <span class="font10">"doctor" </span>
   <span class="font10">"prolonged" </span>
   <span class="font10">"school </span>
   <span class="font10">("SR-physician </span>
   <span class="font10">("Self-Reported </span>
   <span class="font10">(&amp;gt;% </span>
   <span class="font10">()monthly </span>
   <span class="font10">(,, </span>
   <span class="font10">(-%), </span>
   <span class="font10">(-). </span>
   <span class="font10">(.). </span>
   <span class="font10">(AMG </span>
   <span class="font10">(Aurastop©) </span>
   <span class="font10">(CSF) </span>
   <span class="font10">(ED). </span>
   <span class="font10">(EHF) </span>
   <span class="font10">(HV). </span>
   <span class="font10">(ICHD-III) </span>
   <span class="font10">(IHS) </span>
   <span class="font10">(NCT) </span>
   <span class="font10">(O) </span>
   <span class="font10">(SR) </span>
   <span class="font10">(SR-PD) </span>
   <span class="font10">(TN) </span>
   <span class="font10">(TTH), </span>
   <span class="font10">(UCADH), </span>
   <span class="font10">(at </span>
   <span class="font10">(cherub@inwind.it) </span>
   <span class="font10">(group </span>
   <span class="font10">(i) </span>
   <span class="font10">(ii) </span>
   <span class="font10">(mean±SD </span>
   <span class="font10">(mg </span>
   <span class="font10">(mostly </span>
   <span class="font10">(n=,) </span>
   <span class="font10">(n=.K </span>
   <span class="font10">(n=.m </span>
   <span class="font10">(one </span>
   <span class="font10">(p&amp;gt;.) </span>
   <span class="font10">-), </span>
   <span class="font10">-th </span>
   <span class="font10">-week, </span>
   <span class="font10">.%. </span>
   <span class="font10">./. </span>
   <span class="font10">.±.. </span>
   <span class="font10">:S-. </span>
   <span class="font10">;():. </span>
   <span class="font10">;:e. </span>
   <span class="font10">A.O.U. </span>
   <span class="font10">AJ, </span>
   <span class="font10">Acta </span>
   <span class="font10">Activities </span>
   <span class="font10">Adaptive </span>
   <span class="font10">Advanced </span>
   <span class="font10">Aeginition </span>
   <span class="font10">Affairs </span>
   <span class="font10">Ahmed </span>
   <span class="font10">Alba </span>
   <span class="font10">Alessandra </span>
   <span class="font10">Alexandra </span>
   <span class="font10">Also, </span>
   <span class="font10">Animal </span>
   <span class="font10">Annik </span>
   <span class="font10">Annual </span>
   <span class="font10">Antonia </span>
   <span class="font10">Anxiety, </span>
   <span class="font10">Apparatus </span>
   <span class="font10">Appendino </span>
   <span class="font10">Ariane </span>
   <span class="font10">Asha </span>
   <span class="font10">Ashina, </span>
   <span class="font10">Associated </span>
   <span class="font10">Aura </span>
   <span class="font10">Australia, </span>
   <span class="font10">Austria </span>
   <span class="font10">Availability </span>
   <span class="font10">B., </span>
   <span class="font10">BACKGROUND: </span>
   <span class="font10">BMI, </span>
   <span class="font10">Bartoli </span>
   <span class="font10">Behaviour </span>
   <span class="font10">Bergamo; </span>
   <span class="font10">Bevilaqua-Grossi </span>
   <span class="font10">Bias") </span>
   <span class="font10">Biomedicine </span>
   <span class="font10">Bitetto </span>
   <span class="font10">Bladder </span>
   <span class="font10">Blankenbiller </span>
   <span class="font10">BoNT </span>
   <span class="font10">Borro </span>
   <span class="font10">Botox </span>
   <span class="font10">Brescia, </span>
   <span class="font10">Brunelli </span>
   <span class="font10">Brussels, </span>
   <span class="font10">Buffalo, </span>
   <span class="font10">CBF </span>
   <span class="font10">CC, </span>
   <span class="font10">CGRP-induced </span>
   <span class="font10">CH, </span>
   <span class="font10">CI=., </span>
   <span class="font10">CI=.-.); </span>
   <span class="font10">CMMOH </span>
   <span class="font10">CPH. </span>
   <span class="font10">CPTH </span>
   <span class="font10">CT, </span>
   <span class="font10">Cainazzo </span>
   <span class="font10">Canada. </span>
   <span class="font10">Carotenuto </span>
   <span class="font10">Castaldo </span>
   <span class="font10">Catholic </span>
   <span class="font10">Caucasians. </span>
   <span class="font10">Cefalee, </span>
   <span class="font10">Cesaris </span>
   <span class="font10">Cevoli </span>
   <span class="font10">Change </span>
   <span class="font10">Charly </span>
   <span class="font10">Chieti </span>
   <span class="font10">Chieti, </span>
   <span class="font10">Chung </span>
   <span class="font10">Clinicaltrials.gov </span>
   <span class="font10">Cochrane </span>
   <span class="font10">Colombo </span>
   <span class="font10">Common </span>
   <span class="font10">Comorbidities/Endophenotype </span>
   <span class="font10">Company, </span>
   <span class="font10">Complementary </span>
   <span class="font10">Complex </span>
   <span class="font10">Contraception </span>
   <span class="font10">Corporation, </span>
   <span class="font10">Correspondence:Maria </span>
   <span class="font10">Correspondence:Simona </span>
   <span class="font10">Critical </span>
   <span class="font10">Cupini </span>
   <span class="font10">Currently, </span>
   <span class="font10">DAVFs, </span>
   <span class="font10">DC, </span>
   <span class="font10">DS, </span>
   <span class="font10">Dana </span>
   <span class="font10">Davide </span>
   <span class="font10">Dean </span>
   <span class="font10">Deep </span>
   <span class="font10">Del </span>
   <span class="font10">Deneen </span>
   <span class="font10">Departments </span>
   <span class="font10">Desai </span>
   <span class="font10">Diagnostics </span>
   <span class="font10">Dimos </span>
   <span class="font10">Doppler </span>
   <span class="font10">Dose </span>
   <span class="font10">Duisburg-Essen, </span>
   <span class="font10">EA-ID </span>
   <span class="font10">EFNS </span>
   <span class="font10">EQ-D-L </span>
   <span class="font10">EVOLVE- </span>
   <span class="font10">Edoardo </span>
   <span class="font10">Effects </span>
   <span class="font10">Eleonora </span>
   <span class="font10">Eligible </span>
   <span class="font10">Ethics </span>
   <span class="font10">Eusebi </span>
   <span class="font10">Evaluation </span>
   <span class="font10">Everyday </span>
   <span class="font10">FES </span>
   <span class="font10">FLAIR </span>
   <span class="font10">Fang </span>
   <span class="font10">Fayyaz </span>
   <span class="font10">Federation. </span>
   <span class="font10">Federica </span>
   <span class="font10">Fernández-de-las-Peñas </span>
   <span class="font10">Fluoroscopic </span>
   <span class="font10">Follow-up </span>
   <span class="font10">Following </span>
   <span class="font10">Francesc </span>
   <span class="font10">Franco </span>
   <span class="font10">Francois </span>
   <span class="font10">Franznick, </span>
   <span class="font10">Funding: </span>
   <span class="font10">GF, </span>
   <span class="font10">GMB </span>
   <span class="font10">GWAS </span>
   <span class="font10">Gallbladder </span>
   <span class="font10">Galli </span>
   <span class="font10">Gastrointestinal </span>
   <span class="font10">Gaul </span>
   <span class="font10">Giorgia </span>
   <span class="font10">Giulio </span>
   <span class="font10">Glostrup </span>
   <span class="font10">Grade </span>
   <span class="font10">Granato </span>
   <span class="font10">Griffith </span>
   <span class="font10">Grozinski-Wolff </span>
   <span class="font10">Guidi </span>
   <span class="font10">HV, </span>
   <span class="font10">Hallym </span>
   <span class="font10">Hareendran </span>
   <span class="font10">Healthy </span>
   <span class="font10">Heart </span>
   <span class="font10">Hoem </span>
   <span class="font10">Holland </span>
   <span class="font10">Hougaard, </span>
   <span class="font10">ICHD-beta </span>
   <span class="font10">Independent </span>
   <span class="font10">Indianapolis, </span>
   <span class="font10">Insubria </span>
   <span class="font10">International, </span>
   <span class="font10">Iran; </span>
   <span class="font10">Israel. </span>
   <span class="font10">Italia </span>
   <span class="font10">Italiana </span>
   <span class="font10">Italy, </span>
   <span class="font10">Jacob </span>
   <span class="font10">Jose </span>
   <span class="font10">Juanzhi </span>
   <span class="font10">KD, </span>
   <span class="font10">Kapural </span>
   <span class="font10">Kawata </span>
   <span class="font10">Korey </span>
   <span class="font10">LHH </span>
   <span class="font10">Laboratory, </span>
   <span class="font10">Laflamme </span>
   <span class="font10">Lanteri-Minet </span>
   <span class="font10">Leiden </span>
   <span class="font10">Leiden, </span>
   <span class="font10">Licia </span>
   <span class="font10">Lilly </span>
   <span class="font10">Loder </span>
   <span class="font10">Logu </span>
   <span class="font10">London </span>
   <span class="font10">Luca </span>
   <span class="font10">MATERIALS </span>
   <span class="font10">MC, </span>
   <span class="font10">ME, </span>
   <span class="font10">MO. </span>
   <span class="font10">MR, </span>
   <span class="font10">MacGregor </span>
   <span class="font10">MacLeod </span>
   <span class="font10">Madrid, </span>
   <span class="font10">Mann-Whitney </span>
   <span class="font10">Mariana </span>
   <span class="font10">Mattias </span>
   <span class="font10">Melissa </span>
   <span class="font10">Messina </span>
   <span class="font10">Metabolic </span>
   <span class="font10">Michel </span>
   <span class="font10">Michela </span>
   <span class="font10">Misericordia, </span>
   <span class="font10">Mitchell </span>
   <span class="font10">Moscow </span>
   <span class="font10">NNH </span>
   <span class="font10">NRS, </span>
   <span class="font10">NTG </span>
   <span class="font10">Naples, </span>
   <span class="font10">Nassini </span>
   <span class="font10">Nervus </span>
   <span class="font10">Netherlands; </span>
   <span class="font10">Neuromodulation </span>
   <span class="font10">Neuropathic </span>
   <span class="font10">Neuropsychiatry </span>
   <span class="font10">Neuropsychiatry, </span>
   <span class="font10">Neuroradiology </span>
   <span class="font10">Nevertheless, </span>
   <span class="font10">Nice, </span>
   <span class="font10">Nis, </span>
   <span class="font10">Non </span>
   <span class="font10">Nordhaug </span>
   <span class="font10">OH, </span>
   <span class="font10">ONSD </span>
   <span class="font10">Olesen, </span>
   <span class="font10">Open </span>
   <span class="font10">Ordensklinikum </span>
   <span class="font10">P&amp;lt;. </span>
   <span class="font10">P-values </span>
   <span class="font10">P., </span>
   <span class="font10">PAs </span>
   <span class="font10">PEA </span>
   <span class="font10">PI-ID </span>
   <span class="font10">PRESENTATIONS </span>
   <span class="font10">Padua; </span>
   <span class="font10">Parkinson </span>
   <span class="font10">Parma, </span>
   <span class="font10">Percentage </span>
   <span class="font10">Pharmaceuticals </span>
   <span class="font10">Pia </span>
   <span class="font10">Pierangeli </span>
   <span class="font10">Pietrobon </span>
   <span class="font10">Pisa, </span>
   <span class="font10">Pittsburgh </span>
   <span class="font10">Pollastro </span>
   <span class="font10">Pooja </span>
   <span class="font10">Population </span>
   <span class="font10">Post </span>
   <span class="font10">Preliminary </span>
   <span class="font10">Preto, </span>
   <span class="font10">Private </span>
   <span class="font10">Project </span>
   <span class="font10">RE, </span>
   <span class="font10">RPON </span>
   <span class="font10">Radiology, </span>
   <span class="font10">Raieli </span>
   <span class="font10">Rainero </span>
   <span class="font10">Recurrent </span>
   <span class="font10">Regarding </span>
   <span class="font10">Res. </span>
   <span class="font10">Rey </span>
   <span class="font10">Riccardo </span>
   <span class="font10">Ripa </span>
   <span class="font10">Risk </span>
   <span class="font10">Rocco </span>
   <span class="font10">Roma </span>
   <span class="font10">Rome; </span>
   <span class="font10">Ronghua </span>
   <span class="font10">Russian </span>
   <span class="font10">SAFA </span>
   <span class="font10">SAFA-A </span>
   <span class="font10">SDS </span>
   <span class="font10">SF, </span>
   <span class="font10">SM, </span>
   <span class="font10">SR-PD </span>
   <span class="font10">SSDI- </span>
   <span class="font10">SW, </span>
   <span class="font10">Sabina </span>
   <span class="font10">Sacred </span>
   <span class="font10">Sant’Andrea </span>
   <span class="font10">Saul </span>
   <span class="font10">Scale, </span>
   <span class="font10">Scher </span>
   <span class="font10">Science, </span>
   <span class="font10">Scienza </span>
   <span class="font10">Scienze </span>
   <span class="font10">Sechenov </span>
   <span class="font10">Second </span>
   <span class="font10">Serrao </span>
   <span class="font10">Sforza </span>
   <span class="font10">Simone </span>
   <span class="font10">Springer </span>
   <span class="font10">Stefania </span>
   <span class="font10">Store </span>
   <span class="font10">Sunfa </span>
   <span class="font10">Symptom </span>
   <span class="font10">Symptoms </span>
   <span class="font10">Szeged, </span>
   <span class="font10">T., </span>
   <span class="font10">TAMPA </span>
   <span class="font10">TCD </span>
   <span class="font10">Technological </span>
   <span class="font10">Temporomandibular </span>
   <span class="font10">Terrin </span>
   <span class="font10">Teva. </span>
   <span class="font10">Ther </span>
   <span class="font10">Therapy. </span>
   <span class="font10">Thessaloniki, </span>
   <span class="font10">Tian </span>
   <span class="font10">Tolerability </span>
   <span class="font10">Torre </span>
   <span class="font10">Toulouse, </span>
   <span class="font10">Treatments </span>
   <span class="font10">Trials </span>
   <span class="font10">Tricia </span>
   <span class="font10">Triggers </span>
   <span class="font10">Triptans </span>
   <span class="font10">Umberto </span>
   <span class="font10">Unit; </span>
   <span class="font10">Universitario </span>
   <span class="font10">Unna, </span>
   <span class="font10">Urinary </span>
   <span class="font10">Van </span>
   <span class="font10">Vancouver, </span>
   <span class="font10">Varese, </span>
   <span class="font10">Variables </span>
   <span class="font10">Varon </span>
   <span class="font10">Versus </span>
   <span class="font10">Visited </span>
   <span class="font10">Written </span>
   <span class="font10">Yes </span>
   <span class="font10">Yoo </span>
   <span class="font10">Yuan </span>
   <span class="font10">Zonisamide </span>
   <span class="font10">[,,]. </span>
   <span class="font10">[.-.]) </span>
   <span class="font10">[Epub </span>
   <span class="font10">[SR-PD]"). </span>
   <span class="font10">[SR]") </span>
   <span class="font10">abnormality. </span>
   <span class="font10">absenteeism </span>
   <span class="font10">acceptable </span>
   <span class="font10">access, </span>
   <span class="font10">accesses </span>
   <span class="font10">achieved, </span>
   <span class="font10">acting </span>
   <span class="font10">activate </span>
   <span class="font10">activation. </span>
   <span class="font10">activities, </span>
   <span class="font10">adjusting </span>
   <span class="font10">adults, </span>
   <span class="font10">adults. </span>
   <span class="font10">advanced </span>
   <span class="font10">advances </span>
   <span class="font10">adversely </span>
   <span class="font10">affecting </span>
   <span class="font10">affective </span>
   <span class="font10">age-matched </span>
   <span class="font10">agonist </span>
   <span class="font10">agonists </span>
   <span class="font10">ahead </span>
   <span class="font10">al.: </span>
   <span class="font10">allocated </span>
   <span class="font10">allodynia, </span>
   <span class="font10">alone. </span>
   <span class="font10">ambivalent </span>
   <span class="font10">amiloride </span>
   <span class="font10">analyses. </span>
   <span class="font10">analyzed. </span>
   <span class="font10">anatomy </span>
   <span class="font10">angiographic </span>
   <span class="font10">angiography </span>
   <span class="font10">animals </span>
   <span class="font10">ankyrin </span>
   <span class="font10">answered </span>
   <span class="font10">anti-PACAP </span>
   <span class="font10">anticonvulsants </span>
   <span class="font10">approval </span>
   <span class="font10">aspect </span>
   <span class="font10">assesses </span>
   <span class="font10">assessments </span>
   <span class="font10">assuming </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">attractive </span>
   <span class="font10">available. </span>
   <span class="font10">aversion </span>
   <span class="font10">avoiding </span>
   <span class="font10">background </span>
   <span class="font10">baseline; </span>
   <span class="font10">before, </span>
   <span class="font10">beneficial </span>
   <span class="font10">benefit-risk </span>
   <span class="font10">bias </span>
   <span class="font10">biodynamic </span>
   <span class="font10">blockades, </span>
   <span class="font10">blood-brain </span>
   <span class="font10">boards </span>
   <span class="font10">bold </span>
   <span class="font10">bone </span>
   <span class="font10">bowel </span>
   <span class="font10">brain, </span>
   <span class="font10">brief </span>
   <span class="font10">c-statistic, </span>
   <span class="font10">cCH </span>
   <span class="font10">calculated. </span>
   <span class="font10">cancer </span>
   <span class="font10">canonical </span>
   <span class="font10">card </span>
   <span class="font10">careful </span>
   <span class="font10">cases) </span>
   <span class="font10">cause, </span>
   <span class="font10">center. </span>
   <span class="font10">cephalgias </span>
   <span class="font10">changed </span>
   <span class="font10">channel. </span>
   <span class="font10">channels, </span>
   <span class="font10">checked </span>
   <span class="font10">children: </span>
   <span class="font10">classical </span>
   <span class="font10">clear </span>
   <span class="font10">close </span>
   <span class="font10">coenzyme </span>
   <span class="font10">cohorts </span>
   <span class="font10">collection </span>
   <span class="font10">comes </span>
   <span class="font10">communication </span>
   <span class="font10">comorbidity), </span>
   <span class="font10">completely </span>
   <span class="font10">compliance </span>
   <span class="font10">concentration </span>
   <span class="font10">concentrations </span>
   <span class="font10">concerns </span>
   <span class="font10">confirmed/diagnosed </span>
   <span class="font10">conscious </span>
   <span class="font10">considerable </span>
   <span class="font10">considerably </span>
   <span class="font10">content </span>
   <span class="font10">continued </span>
   <span class="font10">contribute. </span>
   <span class="font10">conventional </span>
   <span class="font10">correlate </span>
   <span class="font10">cortex, </span>
   <span class="font10">courier; </span>
   <span class="font10">covering </span>
   <span class="font10">cramps, </span>
   <span class="font10">creation </span>
   <span class="font10">criteria: </span>
   <span class="font10">criterion </span>
   <span class="font10">cumulative </span>
   <span class="font10">cyclase-activating </span>
   <span class="font10">cycle. </span>
   <span class="font10">damage, </span>
   <span class="font10">date </span>
   <span class="font10">date. </span>
   <span class="font10">days/month; </span>
   <span class="font10">debate </span>
   <span class="font10">dedicated </span>
   <span class="font10">degli </span>
   <span class="font10">degrees </span>
   <span class="font10">department. </span>
   <span class="font10">depend </span>
   <span class="font10">depolarization </span>
   <span class="font10">depolarizations. </span>
   <span class="font10">depression. </span>
   <span class="font10">descent </span>
   <span class="font10">details </span>
   <span class="font10">detect </span>
   <span class="font10">developmental </span>
   <span class="font10">diabetes </span>
   <span class="font10">diagnoses </span>
   <span class="font10">diameter </span>
   <span class="font10">diary, </span>
   <span class="font10">diastolic </span>
   <span class="font10">diets </span>
   <span class="font10">diffuse </span>
   <span class="font10">disabilities </span>
   <span class="font10">discharge </span>
   <span class="font10">discrimination </span>
   <span class="font10">disorder? </span>
   <span class="font10">documentation </span>
   <span class="font10">don’t </span>
   <span class="font10">dosing: </span>
   <span class="font10">dysfunction, </span>
   <span class="font10">dysfunctional </span>
   <span class="font10">e.g. </span>
   <span class="font10">efforts </span>
   <span class="font10">elicit </span>
   <span class="font10">em; </span>
   <span class="font10">emotions </span>
   <span class="font10">employees </span>
   <span class="font10">enable </span>
   <span class="font10">endocrine/neurological </span>
   <span class="font10">energy </span>
   <span class="font10">entering </span>
   <span class="font10">entire </span>
   <span class="font10">epilepsy, </span>
   <span class="font10">erythema </span>
   <span class="font10">evaluation, </span>
   <span class="font10">examiner </span>
   <span class="font10">exendin- </span>
   <span class="font10">experience. </span>
   <span class="font10">experiencing </span>
   <span class="font10">explicit </span>
   <span class="font10">explored </span>
   <span class="font10">expression. </span>
   <span class="font10">extend </span>
   <span class="font10">eye </span>
   <span class="font10">eye, </span>
   <span class="font10">eye. </span>
   <span class="font10">fMRI </span>
   <span class="font10">factors: </span>
   <span class="font10">fasciculus </span>
   <span class="font10">fatigue, </span>
   <span class="font10">favorable </span>
   <span class="font10">feasibility </span>
   <span class="font10">feature </span>
   <span class="font10">feeling </span>
   <span class="font10">females, </span>
   <span class="font10">feverfew </span>
   <span class="font10">fewer </span>
   <span class="font10">fibres </span>
   <span class="font10">files </span>
   <span class="font10">filling </span>
   <span class="font10">flags </span>
   <span class="font10">flash </span>
   <span class="font10">flexor </span>
   <span class="font10">forward </span>
   <span class="font10">found. </span>
   <span class="font10">fourth </span>
   <span class="font10">frequently, </span>
   <span class="font10">fulfilled </span>
   <span class="font10">ganglia </span>
   <span class="font10">generate </span>
   <span class="font10">generating </span>
   <span class="font10">generation </span>
   <span class="font10">geniculate </span>
   <span class="font10">goal </span>
   <span class="font10">habitual </span>
   <span class="font10">headache) </span>
   <span class="font10">health-related </span>
   <span class="font10">held </span>
   <span class="font10">hemiparesis </span>
   <span class="font10">hip </span>
   <span class="font10">hospitalization </span>
   <span class="font10">hours) </span>
   <span class="font10">huge </span>
   <span class="font10">hyperactivity </span>
   <span class="font10">hypertension, </span>
   <span class="font10">hypertension. </span>
   <span class="font10">hypotension </span>
   <span class="font10">iOS </span>
   <span class="font10">impairment, </span>
   <span class="font10">implemented </span>
   <span class="font10">impression </span>
   <span class="font10">included, </span>
   <span class="font10">included: </span>
   <span class="font10">inclusion. </span>
   <span class="font10">inclusion/exclusion </span>
   <span class="font10">indication </span>
   <span class="font10">individuals’ </span>
   <span class="font10">indomethacin. </span>
   <span class="font10">inducing </span>
   <span class="font10">induction </span>
   <span class="font10">initially </span>
   <span class="font10">injection-site </span>
   <span class="font10">injections. </span>
   <span class="font10">innervation </span>
   <span class="font10">innovative </span>
   <span class="font10">insecure </span>
   <span class="font10">insomnia </span>
   <span class="font10">instance, </span>
   <span class="font10">integrated </span>
   <span class="font10">integration </span>
   <span class="font10">interactions </span>
   <span class="font10">interested </span>
   <span class="font10">internal </span>
   <span class="font10">intervention. </span>
   <span class="font10">interventions </span>
   <span class="font10">intestinal </span>
   <span class="font10">intestine </span>
   <span class="font10">introduction </span>
   <span class="font10">involve </span>
   <span class="font10">involves </span>
   <span class="font10">is, </span>
   <span class="font10">it. </span>
   <span class="font10">item </span>
   <span class="font10">kept </span>
   <span class="font10">kidney </span>
   <span class="font10">killer </span>
   <span class="font10">kind </span>
   <span class="font10">kinesiophobia, </span>
   <span class="font10">label </span>
   <span class="font10">lacking </span>
   <span class="font10">largest </span>
   <span class="font10">limit </span>
   <span class="font10">limits </span>
   <span class="font10">located </span>
   <span class="font10">low-calorie </span>
   <span class="font10">maintain </span>
   <span class="font10">maintaining </span>
   <span class="font10">male, </span>
   <span class="font10">material </span>
   <span class="font10">max </span>
   <span class="font10">mechanisms, </span>
   <span class="font10">medically </span>
   <span class="font10">medications, </span>
   <span class="font10">medicine. </span>
   <span class="font10">medium </span>
   <span class="font10">menopausal </span>
   <span class="font10">meta-analysis. </span>
   <span class="font10">migraines. </span>
   <span class="font10">migrainosus </span>
   <span class="font10">mimic </span>
   <span class="font10">minutes, </span>
   <span class="font10">modification </span>
   <span class="font10">monitor </span>
   <span class="font10">mothers </span>
   <span class="font10">muscular </span>
   <span class="font10">n=), </span>
   <span class="font10">national </span>
   <span class="font10">nerve. </span>
   <span class="font10">neuropathies </span>
   <span class="font10">neuroradiological </span>
   <span class="font10">ng/mL) </span>
   <span class="font10">nitroglycerin </span>
   <span class="font10">non-ketogenic </span>
   <span class="font10">noninvasive </span>
   <span class="font10">normally </span>
   <span class="font10">numerically </span>
   <span class="font10">obesity </span>
   <span class="font10">obesity, </span>
   <span class="font10">oil. </span>
   <span class="font10">older </span>
   <span class="font10">olive </span>
   <span class="font10">only. </span>
   <span class="font10">ophthalmoplegic </span>
   <span class="font10">opportunity </span>
   <span class="font10">optimize </span>
   <span class="font10">options. </span>
   <span class="font10">oriented </span>
   <span class="font10">overlap </span>
   <span class="font10">overview </span>
   <span class="font10">p-value </span>
   <span class="font10">p=,), </span>
   <span class="font10">p=.), </span>
   <span class="font10">pachymeningeal </span>
   <span class="font10">panic </span>
   <span class="font10">papilledema </span>
   <span class="font10">papilledema. </span>
   <span class="font10">parameters, </span>
   <span class="font10">parenchymal </span>
   <span class="font10">part, </span>
   <span class="font10">partenum, </span>
   <span class="font10">parthenium, </span>
   <span class="font10">partly </span>
   <span class="font10">passive </span>
   <span class="font10">pathogenetic </span>
   <span class="font10">pathologies </span>
   <span class="font10">pattern, </span>
   <span class="font10">period) </span>
   <span class="font10">periods </span>
   <span class="font10">person </span>
   <span class="font10">pharmacotherapy </span>
   <span class="font10">phase, </span>
   <span class="font10">policy </span>
   <span class="font10">poorly </span>
   <span class="font10">position, </span>
   <span class="font10">post-LP </span>
   <span class="font10">pp. </span>
   <span class="font10">practical </span>
   <span class="font10">practice, </span>
   <span class="font10">pre-LP </span>
   <span class="font10">predicting </span>
   <span class="font10">prefer </span>
   <span class="font10">preparation </span>
   <span class="font10">principle </span>
   <span class="font10">procedures, </span>
   <span class="font10">procedures. </span>
   <span class="font10">produce </span>
   <span class="font10">product </span>
   <span class="font10">profile, </span>
   <span class="font10">prognostic </span>
   <span class="font10">program, </span>
   <span class="font10">program. </span>
   <span class="font10">programme </span>
   <span class="font10">promote </span>
   <span class="font10">prompt </span>
   <span class="font10">proved </span>
   <span class="font10">psychological, </span>
   <span class="font10">psychopathological </span>
   <span class="font10">psychotherapy </span>
   <span class="font10">pt;} </span>
   <span class="font10">pts </span>
   <span class="font10">quality. </span>
   <span class="font10">questionnaires. </span>
   <span class="font10">radiofrequency </span>
   <span class="font10">random </span>
   <span class="font10">randomization </span>
   <span class="font10">reach </span>
   <span class="font10">reactions, </span>
   <span class="font10">recommendations </span>
   <span class="font10">recorded. </span>
   <span class="font10">recording </span>
   <span class="font10">records. </span>
   <span class="font10">reduction. </span>
   <span class="font10">referral </span>
   <span class="font10">referral’ </span>
   <span class="font10">referring </span>
   <span class="font10">reflecting </span>
   <span class="font10">regular </span>
   <span class="font10">relevance </span>
   <span class="font10">relies </span>
   <span class="font10">replicate </span>
   <span class="font10">research, </span>
   <span class="font10">resource </span>
   <span class="font10">resources </span>
   <span class="font10">respectively, </span>
   <span class="font10">respectively; </span>
   <span class="font10">respiratory </span>
   <span class="font10">retrospective, </span>
   <span class="font10">s.r.o., </span>
   <span class="font10">sampling, </span>
   <span class="font10">scales </span>
   <span class="font10">seizures, </span>
   <span class="font10">selective </span>
   <span class="font10">self-administered, </span>
   <span class="font10">self-reporting </span>
   <span class="font10">sensitivity. </span>
   <span class="font10">sensitization. </span>
   <span class="font10">sensorimotor </span>
   <span class="font10">series. </span>
   <span class="font10">service </span>
   <span class="font10">settings </span>
   <span class="font10">severity. </span>
   <span class="font10">sheath </span>
   <span class="font10">short-term </span>
   <span class="font10">sign </span>
   <span class="font10">signalling </span>
   <span class="font10">sildenafil, </span>
   <span class="font10">sildenafil. </span>
   <span class="font10">similarities </span>
   <span class="font10">simply </span>
   <span class="font10">sites, </span>
   <span class="font10">smoking </span>
   <span class="font10">sociodemographic </span>
   <span class="font10">solid </span>
   <span class="font10">sought </span>
   <span class="font10">specific: </span>
   <span class="font10">spectroscopy </span>
   <span class="font10">speed </span>
   <span class="font10">standardised </span>
   <span class="font10">status, </span>
   <span class="font10">stay </span>
   <span class="font10">steps </span>
   <span class="font10">stimulation, </span>
   <span class="font10">stimulation. </span>
   <span class="font10">stratified </span>
   <span class="font10">stress, </span>
   <span class="font10">stronger </span>
   <span class="font10">structure </span>
   <span class="font10">styles </span>
   <span class="font10">subgroups. </span>
   <span class="font10">subjective </span>
   <span class="font10">subpopulation </span>
   <span class="font10">subscales </span>
   <span class="font10">subsequently </span>
   <span class="font10">subtype </span>
   <span class="font10">sum </span>
   <span class="font10">summary </span>
   <span class="font10">superficial </span>
   <span class="font10">supports </span>
   <span class="font10">surveys. </span>
   <span class="font10">tablets </span>
   <span class="font10">targeted </span>
   <span class="font10">tender </span>
   <span class="font10">thalamocortical </span>
   <span class="font10">thalamus. </span>
   <span class="font10">thermal </span>
   <span class="font10">tolerability, </span>
   <span class="font10">total, </span>
   <span class="font10">toxins </span>
   <span class="font10">tracts </span>
   <span class="font10">training </span>
   <span class="font10">traits </span>
   <span class="font10">transverse </span>
   <span class="font10">trapezius </span>
   <span class="font10">trial, </span>
   <span class="font10">triptan </span>
   <span class="font10">unpleasant </span>
   <span class="font10">unsatisfactory </span>
   <span class="font10">untreated </span>
   <span class="font10">up. </span>
   <span class="font10">used. </span>
   <span class="font10">utility </span>
   <span class="font10">vary </span>
   <span class="font10">vasoconstriction </span>
   <span class="font10">videos </span>
   <span class="font10">volunteers. </span>
   <span class="font10">want </span>
   <span class="font10">wave. </span>
   <span class="font10">weeks), </span>
   <span class="font10">weight-loss </span>
   <span class="font10">whilst </span>
   <span class="font10">whit </span>
   <span class="font10">wide </span>
   <span class="font10">within-subject </span>
   <span class="font10">work. </span>
   <span class="font10">world </span>
   <span class="font10">worldwide </span>
   <span class="font10">writing </span>
   <span class="font10">years-old </span>
   <span class="font10">yielded </span>
   <span class="font10">zonisamide </span>
   <span class="font10">‘coupon </span>
   <span class="font10">−.; </span>
   <span class="font10">≤.). </span>
  </p>
 </body>
</html>
